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Acute respiratory tract infection (ARI) is the most common reason for 
outpatient medical visits in the United States, and frequently results in treatment 
with an antibiotic. Most ARIs have a viral etiology, thus antibiotic therapy will have 
little clinical benefit in these cases. It is estimated as much as one-half of all 
antibiotic utilization for ARI in outpatient settings is inappropriate. Importantly, this 
misuse is thought to be the primary driver of antibiotic resistance development 
among bacteria. Antibiotic resistant infections cause an estimated 2 million 
illnesses and 23,000 deaths annually in the United States, and associated costs 
exceed $30 billion. Despite our current understanding of relevant predictors of 
appropriate antibiotic use, less is known regarding seasonality. This dissertation 
explores effects of seasonality on antibiotic prescribing in three aspects: 1) 
seasonal variation in appropriateness of prescribing, and antibiotics prescribed 
among common ARIs; 2) specific predictors of observed seasonal variation in 




& quality of care. Findings generated herein, could help inform interventions 
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Background & Significance 
    Due to rapid emergence of antibiotic resistance among bacteria and other 
microorganisms, usage of antibiotics has become an area of intense research 
focus 1,2. Of particular concern is the increasing frequency in detection of so 
called “super bugs”, or bacteria that are resistant to multiple classes of antibiotic 
agents 3. An infection caused by these extremely resistant organisms leads to 
poorer outcomes such as increases in morbidity and mortality 4,5. Inappropriate 
prescribing of antibiotics, especially in the treatment of upper respiratory tract 
infection (URI), is thought to be one factor influencing the development of 
antibiotic resistance among various microorganisms 6,7. As such, efforts to curtail 
antibiotic misuse in these circumstances are urgently needed 8. 
     Respiratory tract infections (RTI) and especially acute respiratory infection 
(ARI) including pneumonia, laryngitis, rhinosinusitis and otitis media are among 
the most commonly diagnosed diseases in the United States and worldwide 9. 
Costs associated with the clinical management of RTIs exceed 30 billion dollars 
annually [US]10. Respiratory diseases range from mild, often self-limiting 
infections to severe illnesses, which can lead to death in extreme cases.  It is 
estimated that RTIs account for nearly half of all days of disability due to acute 
illness in the United States each year and cost associated with these infections 






half of all antibiotic prescriptions written in outpatient settings and one third of 
those written in inpatient settings are indicated for treatment of respiratory 
infections 12. As such, treatment of upper and lower airway infections account for 
large allocations of health service resources, including the use of antibiotics13. 
     In the context of the current research, inappropriate use of antibiotics involves 
overprescribing of these medications and is a global public health concern 14. In 
spite of frequent use of antibiotics to treat diseases of the respiratory tract, the 
viral origin of ARI has been well documented 15,16. It is therefore known that 
antibiotics will have no beneficial effects in the bulk of ARI cases and therefore 
their use in not justified 17,18. Studies have suggested as much as one half of all 
antibiotic use in the United Sates is inappropriate19. Importantly, this misuse is 
thought to act as a key driver in development of antimicrobial resistance 20, as 
well as a significant amount of unnecessary health care expenditures 21.   
     One strategy to reduce inappropriate use of antibiotics for ARI is the 
employment of Point of Care (POC) diagnostic tests designed to distinguish 
bacterial from viral infections. Such tests are often used in both inpatient and 
outpatient settings with some success. Commonly used tests include rapid 
antigen, Polymerase Chain Reaction (PCR), C-reactive Protein, and additional 
molecular biomarker tests such as Procalcitonin. Among tests currently available, 
their uptake is inconsistent, and when utilized significant variation in adherence 






     Seasonal differences in antibiotic utilization have been previously 
demonstrated, with the bulk of antibiotic prescriptions written during winter 
months 12. However, the exact cause of this observed variation is unknown. 
Furthermore, it is unclear if, and to what extent additional provider, patient, and 
environmental factors may interact to influence antibiotic utilization. 
Understanding the root cause(s) of variability in dispensing of antibiotics can help 
with design of meaningful interventions to curb their inappropriate use in clinical 
settings.   
 
Conceptual Framework 
     The proposed study will draw upon elements from Complex Adaptive Systems 
(CAS) theory to inform its conceptual framework. Originally designed to explain 
complexity in biological and mathematical systems with multiple, diverse, and 
interconnected components, CAS models have been adapted to the field of 
health care organizations23. Regarding health services research, CAS theory 
views patients, providers, the larger health care system (payers, organizations, 
etc.), and relevant externalities such as time as independent components whose 
activities are causally linked in so much as upstream behavior(s) of one lead to 
downstream effects on one or more of the others domains. CAS theory further 
considers the assumption that agents in the cascade of health care delivery will 






encounters with unique and dynamic events over time. Previously, CAS theory 
has been used to elucidate strategies to reduce difficult to curtail adverse events 
in health care settings such as patient falls, and hospital acquired infection24,25.  
More recently, CAS theory has been adapted to address inappropriate use of 
pharmaceuticals26. 
     One key aspect of a CAS-based conceptual framework is that CASs are 
considered to exhibit emergent or self-organizing behaviors. While most 
theoretical models assume the future to be predictable, CAS theory suggests 
future activity to be uncertain and based on implicit rules learned and applied 
following interactions between agents. CAS-based explanatory models allow for 
consideration of multiple inputs (including external inputs related to time) and for 
dynamic, unpredictable patterns to emerge. As a result, CAS theory provides a 
useful perspective from which to consider complex behaviors with multiple, 
interconnected agents, such as antibiotic prescribing. Thus, the proposed 
research will focus on theoretically and clinically relevant factors in the context of 
seasonal variation in clinical management of ARIs, and their cumulative effects 
on antibiotic prescribing behaviors, within a CAS theoretical framework.  
 
CAS Model-Based Drivers of Observed Antibiotic Prescribing  
     Several factors have been identified among patients and providers that drive 






include factors that can be conceptualized within a CAS-based framework and 
applied to the study of antibiotic prescribing behaviors in three main domains: 
patient factors, provider factors, and clinical factors.  
     Among patient-level factors, patient age has been associated with 
appropriateness of prescribing, with greater rates of prescribing among children 
compared to adults 27. Patient demographic factors such as race28 have been 
shown to predict guideline appropriate and broad-spectrum prescribing with black 
children less likely than white patients to receive broad-spectrum antibiotics29. 
Patients with lower relative SES and levels of education were more likely to 
receive an inappropriate prescription compared to those with greater SES and 
education levels30. Insurance coverage has also been linked to prescribing 
practices, with privately insured patients being significantly more likely to receive 
an inappropriate prescription for a diagnosed ARI, compared to patients with 
non-private source of payment31. 
     Among the provider domain factors previously associated with prescribing 
behaviors, provider specialty has also been linked to antibiotic prescribing with 
higher rates of prescribing identified among family medicine specialty providers27 
Provider type has been associated with prescribing likelihood in outpatient 
settings. Recently, Schmidt and colleagues reported that advanced practice 
practitioners such as nurses and physician assistants were significantly more 






In addition, career tenure and training location of provider has previously been 
implicated as a predictor of prescribing, as providers who were in mid- or late 
career stage or trained outside of the United States were found to be more likely 
to prescribe antibiotics for ARI33.   
     Among the clinical domain factors previously implicated in antibiotic 
prescribing time pressure has been previously demonstrated as a significant 
predictor of prescribing likelihood. Providers who reported higher patient volumes 
and thereby less time available for each consultation, were more likely to 
prescribe for ARI. Furthermore, there is evidence for a significant dose-effect in 
this domain, where decreases in provider consult time led to proportionate 
increases in likelihood of prescription34. Additional clinical domain factors linked 
to likelihood of prescribing include diagnostic uncertainty and perceived severity 
of disease. Diagnostic uncertainty refers to provider fear of complications in a 
patient and is positively correlated with prescribing likelihood35. Likewise, 
perceptions of greater disease severity were positively associated with likelihood 
of antibiotic prescription among providers36,37. Among health system factors 
correlated with prescribing appropriateness, region is consistently implicated as a 
predictor of prescribing. Studies have routinely found greater rates of antibiotic 
prescribing in the southern region of the US38. Out of office (OOO) hours 
prescribing is another health system factor implicated in prescribing choice. 






more likely to prescribe than health system members that did not offer this 
service39.  
 
Seasonal variation in Prescribing 
     Seasonality in health outcomes is perceived as occurrence of events that 
occur with some predictability, at fixed times, or during specific periods of the 
year40,41. In their landmark study of temporal variation of outpatient antibiotic 
prescribing, Suda and colleagues were able to demonstrate over 2006–2010 
there was significant monthly variation in number and type of antibiotic class 
prescribed during clinic visits. As well, the Suda study identified penicillins, 
macrolides, and quinolones as the most commonly prescribed antibiotics during 
recorded visits. In terms of seasonal fluctuations, the authors’ data suggest 
significantly more antibiotic prescriptions were written during winter months over 
each year of the study12. Durkin and colleagues showed similar patterns among 
penicillin and macrolides in their recent study of antibiotic utilization in a large, 
commercial claims database42.  
     Additional seasonal effects of antibiotic use have been identified with bacteria 
and viruses that causes ARIs. Sun and colleagues identified seasonal correlation 
between community antibiotic use and resistance patterns in E. coli isolates. In 
addition, the authors noted correlation between quinolone use and resistance in 






resistance among isolates of streptococcus pneumoniae, a known bacterial 
cause of OM, were observed among Israeli children during winter months among 
children in Israel44. These data suggest wholesale use of antibiotics can lead to 
rapid and predictable emergence of seasonal resistance among bacteria known 
to influence respiratory health, and should be further characterized.  
 
Antibiotic Appropriateness Measures 
     Overuse is defined as utilization of a care service when risks to a patient 
exceed any potential benefits45. Segal and colleagues have hypothesized that 
while overuse may not be directly observable in health care settings, one should 
be able to measure its effects via comprehensive measurement of various patient 
outcomes46. Segal and colleagues argue that two points should be evident in the 
case of overuse: there should be a net cost to a health care system — that is to 
say, overuse should lead to waste which is not offset in other domains within the 
organization; and secondly, owing to an inherent imbalance toward increased 
risk for harms, overuse should lead to worse patient outcomes. One distinction 
between the work that leads to these conclusions and the focus of the current 
discussion is our focus on antibiotics exclusively.   
     Various studies have demonstrated utility in application of process measures 
such as length of hospital stay (LOS), days of antibiotic therapy47 and defined 






researchers have suggested focusing on outcomes of interest such as resistance 
emergence among bacteria49, prevalence of MRSA or prevalence of Clostridium 
difficile50 as better indicators of quality of antibiotic use.   
     Our definition of appropriateness is a binary one, in which we have defined 
ARIs for which antibiotics are never indicated (e.g. viral pneumonia, bronchitis) 
as inappropriate, and defined ARI diagnoses that always (bacterial pneumonia, 
suppurative otitis media), or sometimes (pharyngitis, sinusitis) indicate an 
antibiotic as appropriate. In the case of the former, a prescription would represent 
overuse, while in the latter case, a prescription would be appropriate use. This 
two-level definition of appropriateness has been applied previously to evaluate 
appropriateness of antibiotic prescribing using NAMCS data30.  
     In their 2018 study on appropriateness of prescribing in primary care, Smith et 
al, utilized a three-tier definition of appropriate selection for their analyses 
estimating antibiotic prescribing rates in outpatient care in the UK51. The authors 
organized a consensus panel of 14 experts to provide estimates of the ideal 
prescribing proportion for common diseases treated with antibiotics. Their group 
estimated that if all prescribing was done appropriately, given known prevalence 
of viral causes of ARI, only 13% (7–22%) of pharyngitis cases should result in an 
antibiotic prescription. This rate can then be used as a benchmark of the ideal 
prescribing portion. Any proportion of prescribing above this standard would be 






than nationwide prescribing rates in order to distinguish appropriate vs 
inappropriate proportion of prescribing52.  
     Guideline concordant prescribing has been utilized as a measure of 
appropriateness for pharyngitis and sinusitis53,54. In their 2018 study, Rahman 
and Sahakian demonstrated there was considerable variation in prescription of 
guideline appropriate, first-line therapies in cases of pharyngitis and OM, 
resulting in an inappropriate antibiotic prescription in roughly one-quarter of 
evaluated cases. Hong and colleagues reported 63% prescribing proportion in 
cases of pharyngitis, but only observed that an American College of Physician 
guideline-appropriate antibiotic was selected in only ~8% of cases.    
     Choice of broad- versus narrow-spectrum agent has recently been examined 
as a measure of overall antibiotic appropriateness. Long-term use of broad-
spectrum antibiotics is associated with increased development of resistance and 
is a growing public health concern55. Studies have previously demonstrated a 
significant increase in use of broad-spectrum agents56,57 and efforts to 
characterize their use as a means to promote more rational consumption of these 
agents have become popular58. 
     It is clear that to effectively reduce inappropriate use of antibiotics, we must 
first be able to accurately and reproducibly quantify these misuse events.  
Quantification of these events will allow researchers to adequately plan 






for increases in spending on research and evidence-based interventions. As 
minimization of waste and reduction of inefficiencies in health care delivery gains 
favor, it is clear that reduction in inappropriate use of pharmaceuticals, and 
particularly antibiotics will be a key player in realization of this goal. Developing 
tools to help quantify the extent of overuse in an effort to predict potential targets 
for reduction efforts, is a crucial first step in this process. Understanding the 
complex interplay between known drivers of antibiotic misuse within the context 
of seasonality, is a key advance of the current research.   
 
Antimicrobial Stewardship  
     One approach designed to guide appropriate use of antibiotics in clinical 
settings is the development and implementation of antimicrobial stewardship 
programs (ASPs)59,60. Antimicrobial stewardship refers to organizational policies 
and / or programs designed to guide appropriate usage of antimicrobial 
compounds within a wide range of clinical settings61. Appropriate utilization is 
based upon recommended indication, as well as patient-specific characteristics 
such as metabolic efficiency and antimicrobial-sensitive organ function. 
Stewardship interventions have proven effective in the past; leading to decreases 
in inappropriate utilization of antibiotic therapy62, use of particular antibiotics47, 
reduction in days of therapy62, and increases in compliance with existing 






that where implemented, stewardship programs are effective in reducing the 
emergence of bacterial resistance to antimicrobials. Additionally, stewardship 
programs have been associated with significant decreases in cost21 and duration 
of antibiotic treatment64. Stewardship programs are comprised of various 
mechanisms including education with regard to appropriate utilization of 
antibiotics, quantification of usage, restriction of availability, and in some cases 
restriction or discontinuation of utilization. However, there is debate and variation 
exists in the optimal method of ASP effectiveness implementation and 
assessment.    
     A key aspect of ASP initiatives is in development and implementation of 
interventions designed to promote appropriate use of antibiotics. These initiatives 
have focused on both patients and providers as targets with some effect 33. 
Multiple mass educational initiatives in Europe were shown to reduce antibiotic 
prescribing for ARI, but these interventions were most effective when targeting 
patients and providers simultaneously65. Peer advising interventions were shown 
to be effective in overall reduction of antibiotic use, as well as use of broad-









     As a preliminary investigation, we conducted a retrospective analysis of 
>7,000 outpatient visits at a large, safety net hospital in Boston, Massachusetts. 
Using ICD-9 coded ARI from study visits, we hypothesized similar patient 
symptomatology may be interpreted differently within the context of seasonality. 
We therefore sought to determine whether timing of clinical encounter acts to 
modify effects of patient symptom presentation on appropriateness of antibiotic 
prescribing for ARI. While we found no significant differences in appropriateness 
of antibiotic prescription based on the patient’s presenting symptoms, we 
observed a slight negative association between incidence of sore throat (p=0.08) 
and marginal effects of season (p=0.07) on prescribing appropriateness. We 
considered our single-site study to be of insufficient size to detect an effect 
among sampled visits, owing to lack of analytical power. However, these data 
informed our subsequent investigations, and search for a larger, more substantial 
data set to address our broader questions concerning effects of seasonality on 
outpatient prescribing behaviors; leading to these dissertation studies.  
 
Dissertation Study Design and Data Source   
     The primary research objective of this dissertation is to determine underlying 
correlates of seasonal variation among various aspects of antibiotic utilization: 






effectiveness of various clinical decision support tools for management of ARIs in 
outpatient settings. The study will employ a retrospective analysis of outpatient 
medical records from 2012–2015. Data will be obtained from the National 
Ambulatory Medical Care Survey (NAMCS). Collected by the Centers for 
Disease Control and Prevention’s (CDC) National Center for Health Statistics 
(NCHS), the NAMCS is an annual population-based, cross-sectional survey of 
patient visits to non-federal, office-based physician practices in the United 
States67. Selection into the NAMCS sampling frame is based upon a 3-stage 
probability sample design. In the first stage the primary sampling unit (PSU), 
which is composed of 112 distinct geographic regions in the US is selected. In 
the next stage, physician practices within each PSU are randomly chosen, and in 
the final stage, patient visits are sampled among physicians within selected 
practices.  Each sampled visit is assigned a survey weight equal to the inverse 
proportion of selection probability into the sample at each stage. As such, the 
application of these weights allows for extrapolation of survey results to nationally 
representative estimates of annual health services utilization in outpatient 
settings in the United States. 
     Main outcome measures are likelihood of appropriate antibiotic prescription, 
by season of clinical encounter. Inappropriateness is defined according to the 
specific aim of each analysis. Briefly, appropriateness is defined as selection of 






antibiotics, or prescription of narrow-spectrum alternatives as first-line therapy. 
Seasonality is defined as Dec–Feb (Winter), Mar–May (Spring), Jun–Aug 
(Summer) & Sep–Nov (Fall). Building upon previous health care research citing 
CAS theory, the proposed studies will seek to explicate seasonal variation in the 
inappropriate utilization of antibiotics in the context of various patient, provider 
and organizational domain factors. Patient factors to be explored include but are 
not limited to age, gender, race and insurance status. Provider factors will 
include provider specialty and provider type. Clinical factors relevant to our 
discussion will include region of practice, MSA, and duration of visit.  
 
Study 1:  Description of seasonal trends in the appropriate utilization of 
antibiotics for clinical management of acute respiratory tract infection (ARI)   
     While seasonal effects on all-cause antibiotic use and class of antibiotic 
prescribed have been described previously12, less is known of seasonal effects 
specific to respiratory tract infection. Moreover, previous studies have been either 
single-site, based in non-US countries or restricted to vulnerable populations 
such as US veterans68 and thus are of limited generalizability to additional 
healthcare delivery systems in the United States. The goal of study 1 is two-fold: 
firstly, to describe seasonal variation in appropriateness of antibiotics prescribed 
for ARIs using nationally representative data; and secondly, to address seasonal 






Hypothesis 1: There will be identifiable seasonal variation in overall 
utilization as well as appropriate utilization, by both number and class, of 
antibiotics for management of RTIs, with greater inappropriate prescribing 
observed in winter months.  
 
Hypothesis 2: There will be identifiable CAS domain (including patient, 
physician and clinical) correlates of observed seasonal variation in 
appropriateness of antibiotic prescribing.  
 
Methodology:  The proposed study will employ time-series analyses of 
retrospective administrative data in order to test for significant effects of 
seasonality on antibiotic prescription. Seasonal effects on both overall and 
appropriate use of antibiotics will be tested independently. Further time-series 
analyses will be employed in order to test for significant differences among 
classes of antibiotics written for RTIs of interest. Finally, regional antibiotic 
utilization data abstracted from the NAMCS database will be compared to 
Centers for Disease Control (CDC), region-specific surveillance data of important 
viral determinants of RTI such as Respiratory Syncytial Virus (RSV), Influenza 
and Adenovirus in order to link observed regional variation to known differences 
in environmental prevalence of critical determinants of RTI. Data on regional 






reporting system and made publicly available by the CDC for research purposes.  
  
Study 2:  Identification of key determinants of observed seasonal variation 
in antibiotic utilization for RTI management   
     While it is known there are seasonal differences in antibiotic prescriptions for 
certain bacterial infections, the key drivers of this phenomenon remain unclear.  
Citing the current as well as previous adaptive CAS theoretical perspectives of 
antibiotic utilization, one may predict that relevant patient, provider and health 
system factors may be important correlates of seasonal trends in their utilization.    
     Building on results from study 1, the goal of study 2 is to examine key CAS-
based patient factors such as age, gender, race, health status and insurance 
type; provider factors such as provider specialty and provider type; as well as 
practice factors such as region, for potential interactions with the external 
influence of seasonality on likelihood of appropriate antibiotic utilization for ARI. 
These tests of seasonal interaction will provide statistical evidence for differential 
effects of our theoretical model factors across levels of season. Further, our 
findings may provide important insight on factors that correlate with seasonal 
trends in antibiotic use. As such, this research could highlight potential targets for 
interventions designed to curtail inappropriate use of antibiotics in health care 






Hypothesis:  There will be identifiable seasonal variation in likelihood of 
appropriate Abx prescribing for Pharyngitis, with greater appropriate 
prescribing observed in fall seasons.   
 
Methodology: In order to test for key correlates of observed seasonal variation 
in antibiotic utilization, study 2 will utilize bivariate and multivariate logistic 
regression models to test for effects on the main outcomes of interest: 
appropriateness of antibiotic prescribing. Univariate analyses will allow for 
identification of likely predictors of appropriate prescribing behaviors.  
Multivariate models will allow for adjustment of these variables to gauge their 
combined effects on observed rates of appropriate prescribing.   
 
Study 3: Seasonal variation in appropriate use of antibiotics for pharyngitis 
and otitis media among adults, and implications for quality    
 
Hypothesis 1:  There will be clear seasonal variation in likelihood of 
guideline concordant Abx prescribing for Pharyngitis, with greater non-
concordant prescribing observed in fall seasons.   
 
Hypothesis 2: There will be clear seasonal variation in likelihood of broad-






prescribing observed in fall seasons. 
 
     While it is known there are seasonal differences in antibiotic prescribing for 
certain bacterial infections, implications for quality of care are less clear. Building 
upon current CAS theoretical perspectives of antibiotic utilization, one may 
predict that relevant patient, provider and health system factors may be important 
correlates of seasonal trends in guideline concordant care. By evaluating the 
likelihood of optimal drug selection, our results may provide greater insight into 
targets of interventions of overall quality in addition to appropriateness of 
antibiotic selection.      
     Building on results from study 2, study 3 is designed to examine CAS 
domain patient factors such as age, gender, race, health status and insurance 
type; provider factors such as specialty and provider type; as well as practice 
factors such as region, for potential interactions with the external influence of 
seasonality on likelihood of appropriate antibiotic selection These interactions will 
provide important insight on factors that may correlate with seasonal trends in 
antibiotic use and importantly provide insights into implications for observed 
variation in care quality. Further, this research will highlight potential targets for 
interventions designed to promote appropriate use of antibiotics in health care 







Methodology   
     In order to characterize observed variation in guideline appropriate and broad-
spectrum antibiotic utilization, study 3 will utilize bivariate and multivariate 
logistic regression models to test for drivers of these two prescribing behaviors. 
Multivariate models will allow for adjustment of study variables to gauge their 
combined effects on observed rates of appropriate prescribing. Guideline 
appropriate therapy is defined by adherence to Infectious Diseases Society of 
America (IDSA) treatment guidelines regarding first-line therapies. Narrow-
spectrum agents can be assessed by their spectrum of activity as defined 
previously69. CAS domain variables are readily obtainable from the NAMCS 
database and their reliability and validity have been demonstrated elsewhere.  
     In order to deepen our understanding of relevant predictors of prescribing 
behaviors, this dissertation is designed to characterize effects of seasonality in 
the context of antibiotic prescribing for ARI. We have focused our analyses as 
three specific aims, each presented in the subsequent chapters. We conclude 
with a summary of main findings, results of hypotheses testing, and a brief 






Study 1: Seasonal Trends In Appropriate Utilization Of Antibiotics For 




     Acute respiratory tract infection (ARI) is one of the most common illnesses 
diagnosed among adults in primary care in the United States and frequently 
results in prescription of an antibiotic70. However, much of the underlying etiology 
of ARI is viral, thus antibiotics confer little to no clinical benefit in these 
cases69,71,72. Worryingly, inappropriate antibiotic use in ambulatory settings is 
seen as the leading driver of antibiotic resistance and a key cause of adverse 
events in patients73. An estimated 2 million antibiotic resistant infections and 
23,000 associated deaths occur annually in the United States, and excess costs 
associated with antibiotic resistance are estimated in the range of $30 to $60 
billion74. Consequently, understanding drivers of inappropriate prescribing is key 
to development of effective interventions designed to curtail this harmful 
behavior.  
     Previous studies have demonstrated critical patient, provider, and practice 
factors associated with outpatient antibiotic utilization. Patient factors such as 
age75, SES, and education level are known to influence likelihood of antibiotic 
prescription30,76–78. Provider factors such as career tenure79, gender80,81, 
specialty38, and diagnostic uncertainty35,82 have also been identified as significant 






such as region38 care setting30,83, and visit duration83 have also been shown to 
significantly predict likelihood of antibiotic prescription among clinicians.   
     Despite our current understanding of relevant predictors of antibiotic 
prescribing in outpatient settings, less is known about the relative effects of 
season of clinical encounter on this behavior. Since prevalence of respiratory 
viruses and bacterial pathogens that cause ARIs are known to vary by season84, 
and to be associated with severity of respiratory disease in adults85, we 
hypothesized that season of clinical encounter may act as a significant driver of 
antibiotic prescribing patterns. Specifically, we hypothesized that clinical 
encounters occurring in winter seasons would be associated with a greater 
likelihood of inappropriate antibiotic prescribing, compared to clinical encounters 
occurring in other seasons. We therefore sought to describe national trends in 
outpatient antibiotic prescribing and the degree to which seasonality acts to 
modify appropriateness of prescribing for management of ARI in adults, from 








Study Design and Data Source 
     In the current study, we conducted a retrospective analysis of data from the 
National Ambulatory Medical Care Survey (NAMCS) from 2012–2015. Collected 
by the Centers for Disease Control and Prevention’s (CDC) National Center for 
Health Statistics (NCHS), the NAMCS is an annual population-based, cross-
sectional survey of patient visits to non-federal, office-based physician practices 
in the United States67. Selection into the NAMCS sampling frame is based upon 
a 3-stage probability sample design. Each sampled visit is assigned a survey 
weight, application of which allows for extrapolation of results to nationally 
representative estimates of annual health services utilization in outpatient 
settings in the United States.  NAMCS data are publicly available and the Boston 
University Medical Campus Institutional Review Board deemed the study exempt 
from human subjects protection review.   
     Over the NAMCS study period, a total of 9,877 physicians were recruited, with 
annual response rates from 28.8% to 41.1%. Upon enrollment, physicians were 
asked to complete a standardized survey form for each sampled visit. In 2013 the 
standard form had space for up to three diagnosis codes and eight medication 
codes. In years 2014 and 2015, the form was expanded to five code fields and 
30 medication fields. Following completion of the survey form, NAMCS personnel 






Revision, Clinical Modification (ICD-9-CM) codes and drug field data into Cerner 
Multum Lexicon drug codes. The Multum Lexicon database is a proprietary data 
system, which contains therapeutic class information for all prescription 
medications available in the US67.  
 
 Study Sample and Definitions 
     The study sample consisted of adults, 18 years of age or greater that visited a 
participating outpatient ambulatory care center, and were diagnosed with an ARI 
during the study period.  These ARI diagnoses (ICD-9-CM code) included 
streptococcal sore throat (034), suppurative and non-suppurative otitis media 
(381, 382), acute nasopharyngitis (460), acute sinusitis (461), acute pharyngitis 
(462), tonsillitis (463), laryngitis & tracheitis (464), non-specific ARI (nsARI) 
(465), bronchitis and bronchiolitis (466, 490), viral pneumonia (480), bacterial 
pneumonias (481–486), and influenza (487).  
     Streptococcal sore throat, suppurative otitis media, sinusitis, and bacterial 
pneumonias were considered ARIs for which an antibiotic is always or may be 
indicated. Accordingly, an antibiotic prescription for one of the above conditions 
was considered appropriate. In contrast, a diagnosis of non-suppurative otitis 
media, nasopharyngitis, pharyngitis, tonsillitis, laryngitis & tracheitis, nsARI, 
bronchitis and bronchiolitis, viral pneumonia, and influenza was considered a 






prescription in these cases was therefore considered inappropriate30.   
     Our study sample was initially drawn from 13,479 eligible patient visits where 
a diagnosis of one of the abovementioned ARIs was recorded. In order to restrict 
our sample to adults, we excluded visits where the patient was less than 18 
years of age. Next, we removed those visits in which a dual diagnosis of an 
antibiotic indicated and non-indicated ARI was noted. Further, since medications 
prescribed at each visit are not linked to a specific diagnosis in the NAMCS data, 
we excluded those visits that noted a concomitant non-ARI diagnosis for which 
antibiotics are appropriate. These rule-out diagnoses (ICD-9-CM code) included 
urinary tract infection (599), non-specific cystitis (595), soft tissue infections 
(680–682), and sexually transmitted infections such as gonococcal diseases, and 
syphilis (90–99, 647).  Additionally, we further excluded visits that noted 
admittance to the ER or hospital.  
     Antibiotics were defined as anti-infective agents according to codes assigned 
in the Multum Lexicon Plus Drug Database67. These database codes are defined 
based on the generic components and therapeutic classification of each antibiotic 
compound. For the current study, the antibiotic classes considered included 
cephalosporins, lincomycin derivatives, macrolides, penicillins, quinolones, 
tetracyclines, and miscellaneous antibiotics.  
     Independent variables of interest included complex adaptive system (CAS) 






and ethnicity (Non-Hispanic Black, Non-Hispanic White, Non-Hispanic Other, 
Hispanic), insurance status (private, Medicaid, Medicare, self-pay, other, 
unknown), chronic obstructive pulmonary disease diagnosis, and tobacco use 
(current, not current, unknown). Provider domain factors included provider 
specialty (General/Family Medicine, Internal Medicine, Pediatrics, other) and 
provider type (physician, physician assistant [PA], nurse practitioner [NP]/nurse-
midwife [NMW], registered nurse [RN] / licensed practical nurse [LPN], other). 
Clinical domain factors analyzed included region of practice (Midwest, Northeast, 
South, West), and Metropolitan Statistical Area (MSA, non-MSA). Seasons were 
defined as winter (December, January, February), spring (March, April, May), 
summer (June, July, August), and fall (September, October, November).  
 
Statistical Analyses  
     In order to account for NAMCS complex survey design, we utilized sample 
clustering, stratification and individual weight variables to determine nationally 
representative estimates and corresponding 95% confidence intervals for 
variables of interest. All years of data were combined in order to increase sample 
size, allowing for greater power in our seasonal analyses.   
     Following adjustment for sampling design, we conducted univariate analyses 
to determine associations between our outcome of interest, appropriateness of 






(continuous) where appropriate.  
     In order to test for appropriateness of prescribing by season, we fit a series of 
logistic regression models, modeling season, a four-level categorical variable, 
and CAS-model patient, provider, and clinical domain covariates on our 
dichotomous prescribing outcome (appropriate/inappropriate). In all cases, the 
clinic visit was treated as the unit of analysis. All analyses were conducted using 











     From 2012 to 2015, there were a total of 205,245 sampled ambulatory care 
visits in the NAMCS database, or a weighted frequency of roughly 3.7 billion 
visits to outpatient clinics in the United States.  The total number of visits 
(weighted frequency) ranged from 76,330 visits (929 million [M]) in 2012 to 
28,332 visits (990M) in 2015. Over the study period, 13,479 visits (270M), or 
roughly 7% included a diagnosis for a specific ARI of interest.  Of these, 7,289 
visits included a patient less than 18 years of age and were excluded. Ninety-five 
visits noted a dual antibiotic indicated and non-indicated ARI diagnosis and were 
excluded from the analyses. Finally, 32 visits resulted in ER admittance and were 
also excluded. In total, 6,063 (132 million) outpatient clinic visits were included in 
the current analyses. 
     The mean (SD) age at each visit was 49.7 (18.5) years. The mean age was 
greatest in spring months, 50.9 years, although this result was not statistically 
significant (p=0.16). The study sample was comprised largely of females 
(n=3,716, 62.3%), and mostly Non-Hispanic whites (n=4,826, 72.2%). No 
significant differences in distribution of gender (p=0.2) or race & ethnicity (p=0.5) 
were observed among seasons. Private insurance (n=3,450, 56.9%) was the 
most commonly recorded source of payment at each visit. We observed a 






payer being the most common insurance type (p=0.03). Physicians 
(n=2,929,45.4%) were the most common provider type seen, with no seasonal 
difference observed among provider type at sampled visits (p=0.8). General and 
Family medicine were the most common specialties represented during each 
clinical encounter (n = 2,747, 47.9%), with no significant differences in specialty 
by season. The bulk of visits (n=2,274, 41.7%) occurred in the South however; 
there were no significant differences in region of visit according to season 
(p=0.9).  (Table 1) 
 
ARI Visits 
     Of the 6,063 total visits during the study period, the most common ARI 
diagnoses (weighted percent) were nsARI / common cold (24%), bronchitis / 
bronchiolitis (21%), sinusitis (13%), and pharyngitis/laryngitis/tonsillitis (13%).  
Otitis media (10%), multiple diagnoses (9%), bacterial pneumonia (4%), influenza 
(3%), and strep throat (2%) were less commonly diagnosed over the study 
period.  
     Of the total ARI related visits during the study period, the majority of clinic 
visits occurred during winter months (32%), followed by spring, (29%), fall (21%), 
and lastly summer (18%). We found no significant difference in the underlying 







     Bronchitis and bronchiolitis were the most common ARIs recorded during 
visits in winter months (21%), fall (21%), and summer (20%). The most common 
ARI diagnosis during spring season was nsARI/common cold (20%), followed by 
bronchitis/bronchiolitis (18%). The least commonly recorded ARIs in each season 
were strep throat (1%–3%) and influenza (1%–4%). ARI diagnoses significantly 
varied according to season of clinical encounter, with the greatest proportion of 
visits occurring during winter months (p<0.0001). (Table 2)   
 
Antibiotic Prescribing  
    Over the study period, antibiotics were prescribed in 3,434 (58%) study 
outpatient visits during which an ARI was diagnosed. After adjustment for sample 
weights, we found roughly 78 million antibiotics were prescribed during visits 
included in the current analyses. The most common diagnoses treated with an 
antibiotic were strep throat (88%), sinusitis (78%), multiple ARI diagnoses (73%), 
and bronchitis/bronchiolitis (70%). Influenza (24%) was the least commonly 
diagnosed ARI treated with an antibiotic.  
     Considering all visits, we found antibiotics were most commonly prescribed 
during winter, (n = 1169; (34%)) and spring (28%), followed by fall (21%) and 
summer (17%) seasons (p= 0.46).  The most common diagnosis associated with 
an antibiotic in each season was bronchitis/bronchiolitis, ranging from a low of 






Sinusitis was the next most commonly prescribed diagnosis, accounting for 
between 18–19% of total ARI prescriptions in each season. In total, bronchitis, 
sinusitis, and nsARI/common cold, accounted for an estimated 56% to 60% of all 
prescriptions written during each season surveyed. In each season, strep throat 
was the least commonly prescribed ARI, representing no more than 4% of total 
seasonal prescriptions over the study period. (Table 3) 
 
Appropriateness of prescribing 
     Of the total visits included in the study, following exclusion of visits wherein 
multiple ARIs were diagnosed concomitantly (n=625), data on a total of 5,438 
visits were available and included in analyses of appropriateness of prescribing. 
Of these visits, antibiotics were appropriately prescribed in 2,950 (54%) of cases. 
Following adjustment for sample weights, we found roughly 57 million antibiotics 
were appropriately prescribed over the study period. This overall measure of 
appropriateness included both prescription of an antibiotic where indicated, as 
well as prohibition of an antibiotic where non-indicated according to treatment 
guidelines.  
     The bulk of appropriate prescriptions were written during winter months 
(n=940), followed by spring (868), fall (596), and summer (546). Similarly, the 
bulk of inappropriate prescriptions were written during winter (798) and spring 






     Sinusitis was the most common ARI for which a prescription was 
appropriately prescribed during each season (20–24%). The second most 
common appropriately prescribed ARI in winter was nsARI/common cold (20%). 
In each of fall, spring, and summer, otitis media was the second most commonly 
appropriately prescribed ARI (20–23%). (Table 4) 
 
Antibiotic Classes Prescribed 
     Overall, the most commonly prescribed classes of antibiotics were macrolides 
(34%) and penicillins (22%). Multiple antibiotics (12%), cephalosporins (10%), 
and quinolones (10%) each were commonly prescribed as well. Less 
represented in our data set were prescriptions for tetracyclines (4%), and 
other/MISC antibiotic class agents (4%). (Figure 1)  
     Macrolides were the most commonly prescribed antibiotic in each season, 
accounting for approximately one-third or more of all prescriptions written. 
Penicillins were the next most commonly prescribed class, accounting for roughly 
one-quarter of all prescriptions written each season. Together, macrolides and 
penicillins accounted for nearly 60% of all prescriptions written over the study 
period. Quinolones and cephalosporins were also frequently prescribed, 
representing approximately 8% to 12% of all prescriptions written each season. 
In total, these four classes of antibiotics accounted for nearly 80% of total 






prescribed, representing a trough of 7% of visits in spring, and a peak of 14% of 
visits in winter. The underlying distribution of antibiotic classes prescribed did not 
vary according to season (p=0.21). (Figure 2) 
 
ARI specific Prescribing Appropriateness, by Season  
     We found no significant association between likelihood of appropriate 
prescription among all ARIs of interest by season of clinical encounter over the 
study period (p=0.49). When we analyzed effects of season on each ARI 
independently we identified a significant association between likelihood of 
appropriate prescribing and season of encounter for both suppurative (p=0.02) 
and non-suppurative OM (p=0.004). (Table 5) An antibiotic prescribed for 
suppurative OM during summer was one-third as likely to be appropriate 
compared to winter [OR (95%CI)] = 0.32 (0.13, 0.79).  However, an antibiotic 
prescribed for non-suppurative OM was nearly three times as likely to be 
appropriate when prescribed during fall [OR (95%CI)] = 2.9 (1.43, 5.95) or during 
summer [OR (95%CI)] = 2.8 (1.26, 6.24) compared to winter. We also found a 
significant association between likelihood of appropriate prescribing and season 
of encounter for acute pharyngitis (p=0.006). An antibiotic prescribed during a 
visit for acute pharyngitis was less than half as likely [OR (95%CI)] = 0.43 (0.25, 
0.73) to be appropriate during fall season compared to winter. (Table 6) Season 






significance as a predictor of antibiotic appropriateness during visits for recorded 
cases of influenza (p=0.05), Strep throat (p=0.06), tonsillitis (p=0.05), or laryngitis 
/ tracheitis (p=0.06). Season was not a significant predictor of likelihood of 
appropriate prescribing during visits wherein a diagnosis of bacterial pneumonia 
(p=0.11), bronchitis / bronchiolitis (p=0.84), nsARI/common cold (p = 0.4), or 








     Our study presents several key findings. Firstly, over the study period a large 
portion of outpatient antibiotic prescribing for acute respiratory tract infection in 
adults remained inappropriate.  In total, nearly half (48%) of all antibiotics 
prescribed for ARIs in outpatient settings over the study period were defined as 
inappropriate. An estimated 12% of prescribing for strep throat was noted as 
inappropriate, while as much as 70% of prescribing for bronchitis was noted as 
inappropriate. Among all diagnoses of OM, an estimated 30% of prescribing is 
inappropriate, while in the case of acute pharyngitis, we found that as much as 
54% of all prescribing was inappropriate. Secondly, in addition to key practice 
and patient factors, the current findings link a portion of the apparent variability in 
appropriate antibiotic prescribing behaviors for specific acute respiratory 
infections to season of clinical encounter.   
      The current findings regarding ARI diagnoses and prescribing patterns are 
similar to results generated from related studies in the United States and 
elsewhere. Previously, Steinman et al reported that sinusitis, nsARI / common 
cold, and acute bronchitis accounted for roughly 70% of all ARI-related adult 
primary care visits in the US86. Here, we found these same conditions to account 
for nearly 60% of all observed ARI cases. Likewise, Fleming-Dutra report, in their 
analysis of antibiotic appropriateness for management of ARI, estimated that as 






identified 46% of ARI visits to be associated with an inappropriate antibiotic 
prescription. 
     Our findings suggest that nsARI/common cold, and pharyngitis diagnoses 
were each prescribed appropriately in approximately half of cases, while 
bronchitis was appropriately prescribed in only 32% of observed cases. Recently, 
diagnoses of pharyngitis were prescribed an antibiotic in 59% of cases88 whereas 
we report pharyngitis diagnoses to be prescribed in 50% of clinic visits. Donnelly 
et al, also recently reported rates of inappropriate antibiotic prescribing to be 
greatest for bronchitis when compared to other ARIs27,38. In the case of 
bronchitis, our result is likely an over estimation of the true proportion of 
inappropriate prescriptions as we did not specifically remove patients with 
comorbid conditions that may indicate an antibiotic, such as chronic obstructive 
pulmonary disease (COPD). However, our findings do suggest that 
overprescribing for bronchitis, which has long been characterized in the 
literature89,90 remains a problem.  
        To the best of our understanding our study is the first to use nationally 
representative data to describe the direct association between season of 
outpatient clinical encounter and likelihood of inappropriate antibiotic prescribing 
for acute respiratory tract infections in adults. We found the bulk of clinic visits for 
ARIs occurred during winter (32%) and spring (29%) months. This finding is not 






March and would likely lead to increased clinic visits for suspected influenza 
cases during these months. In keeping with these findings, Suda et al, also report 
greatest proportion of outpatient antibiotic prescribing during winter months12. 
     The most common ARI diagnoses in winter, spring, and fall seasons were 
bronchitis/bronchiolitis (18–21%), and common cold (18–20%). Although 
bronchitis/bronchiolitis was also the most common diagnosis in summer (20%), 
the next most common diagnosis was sore throat (17%), followed by otitis media 
(16%).  Further, while sore throat was diagnosed most often during summer, this 
diagnosis occurred the least during winter months (11%). This finding suggests 
there may be key differences in care seeking behaviors among patients, 
diagnostic practices among clinicians, and/or prevalence of viral determinants of 
ARI that may help explain observed variation in ARI diagnoses between 
seasons.   
     As one may expect, we noted the greatest proportion of inappropriate 
prescriptions were written during winter and spring seasons. This result makes 
sense given the bulk of clinic visits (32%), and antibiotic prescribing (60%) also 
occur during this same time period. One may suggest increases in inappropriate 
prescribing are likely due to predictable increases in outpatient visits during these 
seasons. Our data suggest alternate explanations for multiple reasons. Firstly, 
while likelihood of appropriateness varies by season when stratified by specific 






point, despite increases in ARI caseload during winter and spring months, 
diagnoses for suppurative OM (an antibiotic indicated condition) are 3 times as 
likely to be appropriate during winter when compared to summer. Likewise, a 
diagnosis of pharyngitis in fall was roughly 40% less likely to be appropriate 
compared to an antibiotic prescribed for this same diagnosis in winter. Thus, 
increases in prescribing volume alone cannot fully explain variation observed in 
our data. Increases in patient volume could lead to reductions in individual visit 
time, and result in increased time pressures that confound the antibiotic 
prescribing event. Previously, time pressure has been linked to increases in 
inappropriate prescribing40,83 while our findings suggest the converse to be true. 
In the case of suppurative OM and pharyngitis, seasons with the least overall 
caseload (summer and fall), also recorded the greatest number of inappropriate 
prescriptions. Inappropriate prescribing should not be seen as an opportunity 
cost due to increased volume at outpatient clinics during winter and spring 
seasons. Additional enquiry remains necessary to disentangle effects of season 
on prescribing behaviors. Lastly, we considered suppurative OM as an antibiotic 
indicated diagnosis and acute pharyngitis as a non-antibiotic indicated diagnosis. 
Despite increased overall likelihood of antibiotic prescription during winter 
months, both antibiotic appropriate and inappropriate diagnoses are prescribed 
more correctly during this time period. This bi-directional effect suggests a further 






warrants further investigation.  
     Our study has limitations we acknowledge. We are utilizing data from 2012–
2015 and recognize that prescribing patterns may have changed since that time. 
Our definition of appropriate is not the only accepted method to define 
appropriateness of prescription. We have chosen a binary approach to 
appropriateness as has been done elsewhere30. However, additional approaches 
that take into consideration the local-level average prescribing rate as the “true” 
benchmark for comparison exist52 and have been reported on in the literature. 
Our approach, while parsimonious may cause unintended loss of information 
critical to ascertainment of “true” appropriateness.  
     A key strength of our research is the use of nationally representative data in 
the outpatient setting. As much as 60% of all costs associated with antibiotics 
occur in outpatient settings12. Thus, there is great opportunity for impact on 
overall effects of inappropriate prescribing by focusing research in this key health 
care setting. As such, future research should continue to focus on the ambulatory 
setting as a key arena for stewardship activities. In addition, future research 
ought to focus on subtleties in the definition of appropriate in order to develop 
and deliver more sensitive tools for evaluating appropriateness in a disease 
specific manner. Finally, it would be worthwhile to investigate seasonal effects on 
antibiotic utilization in additional care settings such as Emergency Departments 






     In summary, our study provides seasonal estimates of prescribing behaviors 
for acute respiratory tract infections among adults, in US- based ambulatory care 
settings. We found that misuse of antibiotics in outpatient settings remains 
excessive and in the case of acute pharyngitis and otitis media, antibiotic 
appropriateness varies significantly according to season. Further research to 
identify and characterize magnitude of seasonal effects on antibiotic utilization 
will allow for greater specificity in development of stewardship and educational 
interventions for health care providers and patients aimed at reduction of well-








Table 1. Demographic Characteristics Of Clinic Visits, 2012–15 (n=6063) 
 












Age (mean, std) 49.7 (18.5) 49.1 (18.2) 50.9 (18.6) 49.1 (19.0) 49.6 (18.4) 0.16
Sex
     Female 3716 (62.3) 1163 (32.4) 1083 (25.2) 681 (20.9)  789 (21.5) 0.2
Race 
     Hispanic 491 (10.6) 169 (34.5) 139 (26.8) 85 (15.6) 98 (23.0)
     Non-Hispanic Black 448 (9.3) 140 (38.2) 145 (26.5) 79 (16.8) 84 (18.5)
     Non-Hispanic Other 298 (7.9) 102 (20.8) 87 (21.1) 55 (25.5) 54 (32.5)
     Non-Hispanic White 4826 (72.2) 1533 (31.4) 1381 (28.2) 878 (20.6) 1034 (19.7)
Insurance
     Private 3450 (56.9) 1112 (29.6) 992 (25.7) 635 (22.9) 711 (21.8)
     Medicare 1413 (21.3) 418 (33.5) 398 (27.9) 258 (17.8) 339 (20.9)
     Medicaid 413 (7.8) 146 (35.8) 109 (26.8) 84 (20.1) 74 (17.2)
     Self-Pay 207 (5.2) 68 (17.0) 82 (47.5) 25 (10.4) 32 (25.1)
     Other/Unknown 580 (8.7) 200 (44.6) 171 (25.6) 85 (12.9) 114 (16.9)
Provider
     Physician 2929 (45.4) 955 (31.0) 843 (27.4) 555 (23.3) 576 (18.2)
     Physician Asst. 232 (4.3) 97 (37.9) 54 (31.5) 43 (11.1) 38 (19.4)
     NP/NMW 148 (2.6) 22 (31.1) 41 (23.7) 31 (11.7) 54 (33.6)
     RN/LPN 1331 (17.4) 396 (29.5) 402(30.1) 228 (18.0) 305 (22.3)
     Other 1423 (30.3) 474 (32.6) 412 (25.4) 240 (18.4) 297 (23.6)
Specialty
     General/Family Med 2747 (47.9) 912 (35.3) 827 (29.8) 460 (15.9) 548 (19.0)
     Internal Med 1261 (27.4) 396 (26.6) 349 (23.6) 249 (28.7) 267 (21.0)
     Pediatrics 209 (2.7) 61 (12.8) 68 (32.9) 37 (18.1) 43 (22.2)
     Other 1846 (21.9) 575 (30.0) 508 (18.8) 351 (18.8) 412 (25.2)
Region
     Midwest 1590 (17.8) 428 (4.13) 560 (29.6) 256 (17.2) 337 (21.7)
     Northeast 798 (17.7) 282 (31.3) 196 (28.7) 161 (18.6) 159 (21.3)
     South 2274 (41.7) 772 (33.6) 579 (25.4) 456 (20.9) 467 (19.9)

















ARI Winter Spring Summer Fall Total p-Value
n (%) n(%) n(%) n(%) n (%)
Otitis Media 218 (11) 268 (15) 171 (16) 196 (15) 853 (14)
nsARI/Common Cold 398 (20) 351 (20) 154 (14) 224 (18) 1127 (19)
Pharyn/Laryn/Tons 220 (11) 225 (13) 183 (17) 162 (13) 790 (13)
Bronchitis 408 (21) 309 (18) 217 (20) 271 (21) 1205 (20)
Influenza 84 (4) 35 (2) 11 (1) 11 (1) 141 (2)
Strep Throat 21 (1) 28 (2) 29 (3) 15 (1) 93 (2)
Sinusitis 283 (15) 221 (13) 158 (14) 175 (14) 837 (14)
Bacterial Pneumonia 106 (5) 113 (6) 78 (7) 95 (7) 392 (6)
>1 Diagnosis 206 (11) 201 (11) 97 (9) 121 (10) 625 (10)











Otitis Media 111 (9) 113 (12) 60 (10) 64 (9) 348 (10)
nsARI/Common Cold 177 (15) 178 (18) 68 (12) 110 (15) 533 (16)
Pharyn/Laryn/Tons 109 (9) 113 (12) 86 (15) 81 (11) 389 (11)
Bronchitis 297 (25) 189 (20) 146 (25) 192 (27) 824 (24)
Influenza 26 (2) 2 (0) 4 (1) 2 (0) 34 (1)
Strep Throat 19 (2) 19 (2) 26 (4) 12 (2) 76 (2)
Sinusitis 225 (19) 171 (18) 112 (19) 126 (18) 634 (18)
Bacterial Pneumonia 50 (4) 45 (5) 24 (4) 37 (5) 156 (5)
>1 Diagnosis 155 (13) 133 (14) 62 (11) 90 (13) 440 (13)
Total 1169 (100) 963 (100) 588 (100) 714 (100) 3434 (100)
0.54
ARI
Winter Prescribed  
 n(wt%) p-value
Spring Prescribed  
n(wt%)






























Otitis Media 145 (15) 195 (22) 123 (22) 138 (23) 601 (20)
nsARI/Common Cold 221 (23) 173 (20) 86 (16) 114 (14) 594 (20)
Pharyn/Laryn/Tons 111 (12) 112 (13) 97 (218) 81 (13) 401 (14)
Bronchitis 111 (12) 120 (14) 71 (13) 79 (1) 381 (13)
Influenza 58 (56) 33 (4) 7 (1) 9 (5) 107 (4)
Strep Throat 19 (2) 19 (2) 26 (5) 12 (2) 76 (3)
Sinusitis 225 (24) 171 (20) 112 (20) 126 (20) 634 (21)
Bacterial Pneumonia 50 (5) 45 (5) 24 (4) 37 (6) 156 (5)














ARI !2 p Value
OM 5.96 0.03




Strep throat 9.74 0.06
Sinusitis 8.53 0.9
Bacterial Pneumonia 5.86 0.11






Table 6.  Odds of Appropriate Antibiotic Prescribing to Adults diagnosed 
























ARI Season OR (95%CI) p-Value
Winter ref
Spring 0.53 (0.22, 1.31)
Summer 0.32 (0.13, 0.79)
Fall 0.76 (0.27, 2.16)
Winter ref
Spring 1.16 (0.63, 2.14)
Summer 2.8 (1.26, 2.14)
Fall 2.92 (1.43, 5.95)
Winter ref
Spring 0.88 (0.51, 1.53)
Summer 1.08 (0.55, 2.12)









Figure 1. Classes of Antibiotics Prescribed to Adult Outpatients with Acute 


























































Figure 2. Classes of Antibiotics Prescribed to Adults with Acute 
















































Study 2: Identification Of Key Determinants Of Observed  
Seasonal Variation In Antibiotic Utilization For ARI  
 
Introduction 
     Development of anti-infectives, including antibiotics, is among the most critical 
advances in modern medicine. However, the distribution of antibiotic resistance 
among common bacterial pathogens is increasing and resistance patterns are 
constantly evolving as a response to selective pressure38. Moreover, as 
resistance to common antibiotics grows, development of novel antibiotic agents 
has lagged91,92. In 2013, the Centers for Disease Control and Prevention (CDC) 
estimated that in the United States there are 2 million antibiotic resistant 
infections and 23,000 associated deaths annually (CDC, 2013), at an estimated 
cost of $30 billion74.  
     Ambulatory care visits account for approximately 60% of all antibiotic 
prescribing in the US each year12. Worryingly, among outpatient care visits for 
acute respiratory infections (ARI), as much as one-third of all antibiotic 
prescriptions are unnecessary71. Over-utilization of antibiotics in primary care is 
seen as the leading driver of resistance patterns among bacterial pathogens93. 
Complicating the issue of prescribing in ARI cases is that viruses cause many 
diseases of the airway and antibiotics prescribed in these cases offer no clinical 
benefit86. Since antibiotic misuse is associated with observed community-wide 






reactions96,97, appropriate use of antibiotics is a key public health concern.  
     Previous research has identified key patient, provider, and health system 
factors which predict appropriate antibiotic selection. Relevant CAS patient 
domain factors which significantly predict antibiotic selection include age75 
SES76,77, and level of education76,77. CAS Provider domain factors such as tenure 
of career and specialty 38 have each been identified as significant predictors of 
appropriate prescribing. Finally, clinical and health system domain factors such 
as out-of-office hours prescribing98, and care network membership have also 
been implicated as key drivers of prescribing behavior.  
     Currently, less is known regarding effects of season and potential interactions 
with previously identified factors. Since prevalence of common bacterial and viral 
pathogens is known to vary by season, we sought to characterize seasonal 
effects on likelihood of appropriate antibiotic selection among acute pharyngitis 
and otitis media (OM) patients. Given results from our preliminary data, we 
hypothesized there would be increased inappropriate antibiotic prescribing 
observed in fall seasons during pharyngitis visits. Pharyngitis and OM were 
selected since 1) they are common diseases of the airway with known viral 
etiology 54 and 2) preliminary results from related analyses of NAMCS data 








Study Design and Data Source 
     Our findings are informed by, and utilize data from the National Ambulatory 
Medical Care Survey (NAMCS), 2012 – 2015. Collected each year by the 
National Center for Health Statistics, NAMCS is a nationally representative 
sample of patient visits to ambulatory care clinics in the United States. Each 
year, physicians are randomly selected to participate and provide information 
detailing patient encounters. Following selection into the survey, physicians are 
then asked to complete a standardized encounter form, with information 
regarding diagnoses and treatment for each visit detailed. These completed 
forms allow study team members to capture important details regarding each 
clinic visit. Eligible visits include all outpatient ambulatory visits for adults 
diagnosed with acute pharyngitis and otitis media (OM) between 2012–2015. 
 rom 2012, forms allotted up to 10 diagnoses and medications. After this 2012 up 
to 30 fields for medications prescribed at each visit were included. At each visit, 
International Classification of Diseases, Clinical Modification (ICD-9-CM) codes 
were applied and noted to identify ARI diagnoses.  
     Our study sample was initially drawn from 13,479 eligible patient visits where 
a diagnosis of one of the abovementioned ARIs was recorded. We first excluded 
patient visits where the patient was less than 18 years of age. Next, we removed 






ARI was noted. Visits in which multiple antibiotics were prescribed were dropped 
from analyses.  
     Selection into the NAMCS sample is based upon a 3-stage probability sample 
design. Each visit is then assigned a survey weight equal to the probability of 
sample selection. As a result, sample weights can be applied in order to estimate 
national trends regarding outpatient prescribing behaviors in the United States 
each year.   
 
Study Sample and Definitions 
     The study samples draw upon all ARI-related patient visits which were 
associated with a primary, secondary, or tertiary diagnosis of pharyngitis (462) or 
otitis media (381, 382). We excluded visits where multiple ARI diagnoses were 
noted as we are not able to track diagnoses to specific prescriptions in the 
NAMCS database. Prescribing for both pharyngitis and non-suppurative OM 
were considered inappropriate for the current analyses and thus represent over-
utilization of antibiotics. Antibiotic prescribing for suppurative OM was considered 
appropriate30. Antibiotics were defined as any all Multum Lexicon coded anti-
infective agents that were prescribed during the clinical encounter.  We classified 
antibiotic agents as macrolides, quinolones, penicillin, cephalosporins, 
miscellaneous antibiotics agents, and more than one antibiotic prescription. For 






analysis.   
     Following completion of the NAMCS survey form, study personnel converted 
diagnosis data into International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) codes and drug field data into Cerner Multum 
Lexicon drug codes. The Multum Lexicon database is a proprietary system, 
which lists therapeutic class information for all prescription medications available 
in the United States67. 
 
Statistical Analyses  
     For each analysis, complex survey design criteria were applied, such that 
predictors of outcomes could be extrapolated and made to be nationally 
representative. Study samples are given a sample weight equal to the inverse 
probability of its selection from the sample universe. Univariate analyses were 
completed following adjustment for patient and visit variable weights. Multivariate 
regression was then performed adjusting for all clinically relevant variables, as 
each has previously been associated with appropriateness of antibiotic 
prescribing. In order to evaluate effects of season on prescribing behaviors, we 
examined interactions with main effects variables and our categorical season 
variable. 
     Independent variables of interest included CAS model-based patient domain 






Non-Hispanic Other, Hispanic), insurance status (private, Medicaid, Medicare, 
self-pay, other, unknown), chronic obstructive pulmonary disease diagnosis, 
tobacco use (current, not current, unknown), and total number of chronic 
conditions recorded at each visit; provider domain factors: provider specialty 
(General/Family Medicine, Internal Medicine, Pediatrics, other), and provider type 
(physician, physician assistant [PA], nurse practitioner [NP]/nurse-midwife 
[NMW], registered nurse [RN] / licensed practical nurse [LPN], other); and clinical 
and health system domain factors: region of practice (Midwest, Northeast, South, 
West), Metropolitan Statistical Area (MSA, non-MSA), and visit duration in 
minutes. Season was defined as winter (December, January, February), spring 
(March, April, May), summer (June, July, August), and fall (September, October, 
November). Antibiotic data were recorded from Cerner Multum Lexicon drug 
codes.  
     All analyses were performed using SAS version 9.4 (Cary, NC; USA) and p < 
0.05 was considered significant. As all data are de-identified and publicly 
available, the institutional review board at Boston University School of Public 









     Of total pharyngitis and OM visits (N = 4,416) recorded in the NAMCS 
database from 2012–2015, rule-out diagnoses (ICD-9-CM code) of urinary tract 
infection (599), cystitis (595), various soft tissue infections (680–682), and 
sexually transmitted infections (90–99, 647) were tallied, and visits which 
included these codes were removed from our final cohort. These n = 29 visit 
diagnoses were excluded as each may indicate appropriate prescription of an 
antibiotic and could confound results. Additionally, we excluded 2,329 visits that 
noted a patient under 18 years of age to ensure our analyses were restricted to 
visits involving adults. 
     Following exclusion of cases that did not meet inclusion criteria, there were a 
total of 2,058 visits in the NAMCS database eligible for analyses, from 2012 to 
2015. Of these total cases, 1,205 visits were noted as a diagnosis of pharyngitis 
and 853 were recorded as having a diagnosis of OM. Mean age (± standard 
deviation) among total visits was 47 ± 18.6 years. Mean age recorded among 
pharyngitis visits was 42 ± 18.3 years. Mean age recorded among OM visits was 
52 ± 17.7 years. Mean time spent at each visit was approximately 19 minutes for 
each ARI condition. Our study population was comprised of predominately (82%) 
non-Hispanic whites, and 60% female participants. Non-Hispanic whites 






of payment for clinic visits was predominately private source for all visits (53%). 
Private insurance was the most common payment type for OM (60%), and 
pharyngitis visits (65%). Collectively, Medicaid (7%) and Medicare (27%) 
payment source comprised 34% of study visits. Approximately half of study visits 
involved a physician as the provider during OM office visits (50%), and 
pharyngitis visits (48%).  Study demographic data are found in Table 7.  
 
Antibiotic Prescribing  
     In total, antibiotics were prescribed in 46% of all outpatient visits. 
Approximately 40% of cases for OM and 50% of visits related to pharyngitis 
diagnosis resulted in an antibiotic prescription. Macrolides (35%) and penicillins 
(34%) accounted for the bulk of all antibiotic prescriptions written. In the case of 
OM, 33% of prescriptions written were for penicillins, while macrolides accounted 
for approximately 12% of total antibiotic prescriptions noted. Multiple antibiotics 
were prescribed in 15% of OM visits. In the case of pharyngitis visits, macrolides 
were prescribed in 35% of visits, while penicillin prescription was noted in 34% of 
visits. Overall, we identified 49% of prescribing for pharyngitis and 30% of 
prescribing for OM as inappropriate.  (Figure 3) 
 
Predictors of Observed Seasonal Prescribing Variation  






variables were significantly associated with likelihood of prescribing 
appropriateness. The main effect of season was not significantly correlated with 
antibiotic appropriateness during study visits (p=0.6), when all ARI diagnoses 
were evaluated concurrently. However, race (p=0.0007), insurance type 
(p=0.005), and COPD status (p =0.04) were identified as significant predictors of 
appropriate prescribing during all OM and pharyngitis office visits over the study 
period (Table 8).   
     When visits were further stratified by ARI, among OM visits, season was 
identified as a significant predictor of appropriate antibiotic selection (p=0.03). 
Visits associated with the greatest proportion of inappropriate prescriptions 
occurred equally during spring (31%) and winter (31%) months. Following 
multivariate modeling, we identified insurance status (p =0.0003), provider type 
(0=0.01) and patient age (0.0008) as main effects which significantly predicted 
appropriateness of antibiotic prescribing at each recorded OM visit.  
     Following bivariate analyses, we next fit multivariate logistic regression 
models, controlling for all significantly predictive variables. In our adjusted model, 
we identified age as highly predictive of inappropriate prescribing, with 
approximately 2% increased odds of inappropriate antibiotic selection with each 
year increase in patient age. (<0.0001). Further, inappropriate antibiotics were 
more likely to be prescribed during fall season compared to winter (p=0.02). 






having a seasonal interaction on likelihood of appropriate prescribing (p=0.03) 
during OM visits (Table 9). Unknown payment type was associated with one-
quarter the odds of appropriate antibiotic selection, compared to self-pay patients 
[OR (95% CI)] [0.25 (0.07, 0.98)]. 
     We next fit multivariate models for pharyngitis visits, and adjusted for identical 
covariates from univariate analyses. Among pharyngitis visits, age (p=0.0008) 
was identified as a main effect which significantly predicted appropriate antibiotic 
selection. A one-year increase in patient age was associated with approximately 
2% increased odds of inappropriate antibiotic selection during pharyngitis visits. 
Further, insurance status (p<0.0001), and provider type (p = 0.05) were identified 
as having significant interactions with season of clinical encounter. Patients that 
paid for clinical services out-of-pocket had only 20% odds of appropriate 
antibiotic selection compared to patients with private insurance [odds ratio (95% 
CI)] [0.18 (0.06, 0.5)]. In addition, physicians were approximately 1.5 times [OR 
(95% CI)] [1.6 (1,1. 2,4)] as likely to prescribe antibiotics appropriately, compared 








     Our study has several main findings. In the context of antibiotic prescribing for 
otitis media and pharyngitis, season of clinical encounter was a significant 
predictor of appropriate antibiotic selection in each case. Further, age and 
insurance status were each significantly predictive of antibiotic appropriateness 
among OM and pharyngitis visits. Importantly, among OM visits we identified 
differential effects of insurance status on likelihood of antibiotic prescribing. 
Among pharyngitis cases, we observed differential effects of insurance status 
and provider type across season of clinical encounter. In each case, these 
effects remained significant after controlling for additional covariates. Unlike prior 
studies, our data are the first to provide evidence that season of encounter is a 
significant predictor of appropriate antibiotic selection for these common 
respiratory infections and provides further context as to how season drives 
antibiotic prescribing behaviors during ARI-related ambulatory care visits.  
     Previously, patient and provider covariates such as patient gender99,  
race 28 and locality have been identified as predictive of appropriate antibiotic 
selection. Our data do not provide support for significant effects of these 
variables on likelihood of appropriate antibiotic selection among OM and 
pharyngitis cases. Patient age36 and provider type38 have each been found to 
predict likelihood of appropriate antibiotic selection in previous studies. Our 






type on antibiotic prescribing behaviors among OM and pharyngitis outpatient 
visits, after controlling for season of clinical encounter.   
     Older patients were significantly more likely to receive inappropriate 
antibiotics in cases of OM and pharyngitis. It is likely providers see older patients 
as particularly vulnerable. As a result, providers may be more likely to prescribe 
to older patients in an effort to mitigate unforeseen complications of respiratory 
infection. Diagnostic uncertainty has previously been implicated as a significant 
predictor of antibiotic selection35,82. In our opinion, diagnostic uncertainty may be 
at play in the case of a visit with older adults. Increased likelihood of 
inappropriate antibiotic selection according to age was identified in both OM and 
pharyngitis cases, suggesting the overall import of this covariate regarding 
antibiotic selection. Moreover, age represents a useful target for development of 
stewardship and educational opportunities regarding improvements in antibiotic 
prescribing.    
     There is less support for differential effects of insurance status on likelihood of 
prescribing. Here, we provide evidence that in the context of prescribing for OM 
and pharyngitis, insurance status is a significant predictor of seasonal antibiotic 
selection. Out of pocket payment is associated with lack of insurance100. As a 
result, these patients who self-pay may be more likely to be of lower SES than 
privately insured patients. Perhaps patients that self-pay are more likely to treat 






deliverable. These patients may be more persistent in their asking for an 
antibiotic prescription during the clinical encounter. Also, given their relative low-
cost, antibiotics may be seen as a cost-effective approach to management of ARI 
among self-pay patients and their providers. Also, providers may see patients 
with reduced means of payment as needing an antibiotic prescription. SES has 
been previously been found to be predictive of appropriate antibiotic selection. 
We also present evidence here in support of this finding, by proxy with expected 
source of payment as a model covariate. Further investigations of impact of 
payment type for antibiotic medications should be conducted in order to describe 
how payment type and seasonality may drive appropriate antibiotic selection in 
ARI ambulatory care visits.  
     We recognize limitations associated with our study. As with any analysis of 
survey data there is the inherent potential for sampling bias. However, study 
design of the NAMCS survey and sampling procedures should help to mitigate 
these effects. A further limitation of the NAMCS data set is that one cannot link 
prescriptions to specific diagnoses. Since we did not restrict data to those where 
an ARI was the primary diagnosis, it is possible, that a concomitant antibiotic 
indicated diagnosis, rather than the ARI noted at the clinic visit, was the “real” 
cause of antibiotic prescription. Unfortunately, we cannot reliably make this 
distinction with NAMCS data. Future studies of antibiotic appropriateness need to 






dependably determine appropriateness of antibiotic prescribing for ARI. We have 
also approached appropriateness of prescribing in a binary fashion. Other 
studies take a more nuanced approach and incorporate regional prescribing 
rates 38, or consensus panel determination of appropriateness100. Thus, our 
approach may represent an overestimation of the “true” proportion of 
inappropriate prescribing for OM and pharyngitis. However, our findings are in 
line with what has been presented previously and as a result, we are confident in 
their validity. Finally, otitis media is a common pediatric illness and most studies 
of this disease focus on children. Our findings provide data describing prescribing 
behaviors among adults with OM, and add to our current understanding among 
this sub-population of patients.  
     To the best of our knowledge, our study is the first to present significant 
effects of season of clinical encounter and appropriateness of prescribing for 
otitis media and pharyngitis. Moreover, we have provided evidence in support of 
significant interactions between season of clinical encounter with insurance, and 
provider type in the case of OM & pharyngitis. Further, our findings are nationally 
representative and thus can be generalized to outpatient visits in the United 
States for adults diagnosed with pharyngitis or OM. Previous studies regarding 
antibiotic selection have been single site and / or non- US based. Thus, our 
findings are relevant to the entire adult, US population.   






remains a significant issue in ambulatory care. Previously, studies have identified 
key patient and provider factors associated with antibiotic appropriateness. Our 
data suggest insurance coverage and provider type as additional factors that 
interact within the context of seasonality as predictors of likelihood of appropriate 
antibiotic prescribing for OM and pharyngitis visits. As a result, our data provide 
targets for development of useful antibiotic stewardship and educational 
activities. For example, specific training can be developed and delivered, based 
on findings presented here, to those provider types that perform marginally worse 
at antibiotic prescribing. Educational interventions may benefit from a focus on 
types of conversations that may prove crucial to the prescribing process, based 
on patient insurance coverage. Increased involvement of patients in the care 
process, including discussions regarding antibiotic prescribing, could be a useful 
goal for healthcare providers, in an effort to prevent inappropriate antibiotic 








Tables & Figures 








     Female
Race 
     Hispanic
     Non-Hispanic Black
     Non-Hispanic Other
     Non-Hispanic White
Insurance
     Private
     Medicare
     Medicaid
     Self-Pay
     Other/Unknown
Provider
     Physician
     Physican Asst
     NP/NMW
     RN/LPN
     Other
Specialty
     General/Family Med
     Internal Med
     Pediatrics
     Other
Region
     Midwest
     Northeast
     South
     West 
Season
     Winter                                                           
     Spring
     Summer
     Fall 
47.9 (18.5) 51.7 (17.3) 43.0 (18.3)
Total n (%) N=2058 Pharyngitis n(%) n=1205 OM n(%) n=853
1306 (87) 7445 (87.3) 561 (86.0)
19.1 (12.9) 19.0 (11.2)
3716 (62.3) 1163 (32.4) 1083 (25.2)
110 (7.3) 43 (5.0) 67 (10.3)
81 (5.4) 32 (3.7) 49 (7.5)
1225 (81) 732 (85.8) 493 (75.6)
89 (5.9) 46 (5.4) 43 (6.6)
509 (59.7) 420 (64.4)
205 (24.0) 85 (13.0)
929 (61.7)
290 (19.3)
124 (8.2) 57 (6.7) 67 (10.3)
59 (6.9) 53 (8.1)
23 (2.7) 27 (4.1)
112 (7.4)
50 (3.3)
50 (3.3) 24 (2.8) 26 (4.0)
27 (1.8) 11 (1.3) 16 (2.4)
740 (49.2) 429 (50.3) 311 (47.7)
349 (23.2) 194 (22.7) 155 (2.8)
339 (22.5) 195 (22.9) 144 (22.1)
45 (4.8) 11 (2.2) 34 (8.1)
429 (46.2) 323 (63.5) 106 (25.2)
334 (36) 135 (26.5) 199 (47.4)
121 (13) 40 (33.1) 81 (19.3)
410 (27.2) 110 (12.9) 168 (25.8)














235 (27.6)381 (25.3) 146 (22.4)







Table 8 Demographic Characteristics Associated With Appropriateness Of 




Age (mean, std) 0.33
Chronic Conditions (mean, std) 0.002




     Female
     Male
Race 
     Hispanic
     Non-Hispanic Black
     Non-Hispanic Other
     Non-Hispanic White
Insurance
     Private
     Medicare
     Medicaid
     Self-Pay
     Other/Unknown
Provider
     Physician
     Physican Asst
     NP/NMW
     RN/LPN
     Other
Specialty
     General/Family Med
     Internal Med
     Pediatrics
     Other
Region
     Midwest
     Northeast
     South
     West 
Season
     Winter                                                           
     Spring
     Summer






1087 (52.8) 829 (53.9)
101 (4.9) 47 (4.8)
149 (7.2) 69 (7.0)
130 (6.3) 61 (6.2)
68 (3.3) 29 (2.9)
186 (9.0) 88 (9.0)
570 (27.7) 266 (27.1)
147 (7.1) 70 (7.1)
486 (23.6) 215 (23.9)
36 (1.7) 17 (1.7)
462 (22.4) 202 (20.1)
1010 (49.1) 513 (52.2)
64 (3.1) 35 (3.6)
841 (40.9) 510 (51.9)
382 (18.6) 139 (14.1)
39 (1.9) 18 (18)
796 (38.7) 3115 (32.1)
Inappropriate (n=1076)
1730 (84.1) 847 (86.2)
53.3 (17.8) 53.7 (17.9) 52.9 (17.8)
1.38 (2.0) 1.2 (1.9)
Total (N=2058) Appropriate (n = 982)





16787 (815) 805 (82.0)
812 (39.5) 376 (38.3)












556 (27.0) 136 (13.8)
253 (12.3) 266 (27.1)
290 (26.9)
328 (33.4)763 (37.1) 435 (40.4)
117 (109) 0.9
982 (47.7) 250 (23.2)
370 (34.4)
3115 (32.1) 262 (24.3)
194 (19.8) 194 (18.0)
256 (26.1)
0.6

















Table 9. Model of seasonal predictors of antibiotic prescribing, OM 
 
Variable Unadjusted estimate  Adjusted estimate 
  F Vaulue p F Vaulue p 
Season 3.1 0.03 4.2 0.006 
Age -0.02 <0.0001 24.7 <0.0001 
Insurance 0.14 0.14 0.03 0.85 









Table 10. Model of seasonal predictors of antibiotic prescribing, 
Pharyngitis 
 
Variable Unadjusted estimate  Adjusted estimate 
  F Vaulue p F Vaulue p 
Season 0.25 0.86 1.49 0.22 
Age 0.02 <0.0001 0.55 0.65 
insurance 0.08 0.41 4.74 0.03 
Provider -0.13 0.03 0.05 0.82 
Insurance*season 0.18 0.914 4.04 <0.0001 



































Study 3: Seasonal Variation In Appropriate Use Of Antibiotics For 
Pharyngitis And Otitis Media Among Adults, And Implications For Quality    
 
Introduction 
     Acute respiratory infections (ARI), including pharyngitis, sinusitis, and otitis 
media are the most common cause of outpatient care visits and antibiotic 
prescriptions in the Unites States70. Each year, there are approximately 100 
million ARI-related ambulatory care visits among adults in the US, and an 
antibiotic is prescribed in an estimated 41% of cases75,97.  
     Pharyngitis alone accounts for approximately 1%–2%, or approximately 12-
million outpatient care consults each year54. As with many diseases of the 
airway, pharyngitis tends to be self-limiting and is known to have a predominantly 
viral etiology. Currently, the only indication for antibiotics in cases of pharyngitis 
is for episodes with known group A streptococci (GAS) origin.  
     It is estimated that only 5%–17% of acute pharyngitis cases are due to GAS 
infection53. Thus, antibiotics offer little to no clinical benefit in most cases where 
they are administered. However, despite this relatively low number of cases 
meeting requisite clinical criteria, antibiotic therapy for pharyngitis is initiated in 
upwards of 70% of outpatient visits89.  
     Overuse of antibiotics for management of ARI is a significant public health 
concern. Misuse of these agents is associated with development of antibiotic 
resistance patterns. In the US, bacteria that exhibit resistance to antibiotics are 






annually. In addition, overuse of antibiotics is estimated to cause upwards of 20% 
of all adverse medical events that lead to an ED visit. For example, opportunistic 
infections caused by Clostridium difficile are known to associate with antibiotic 
overuse and result in increased morbidity and healthcare costs among those 
infected96.  
     In an effort to promote rational utilization of antibiotics, health care providers 
have initiated antimicrobial stewardship programs (ASPs). The goal of ASPS is to 
ensure correct selection, including but not limited to, dose and timing of 
antimicrobials, in an effort to reduce their misuse and prevent development of 
antibiotic resistance.  
     There are many mechanisms by which ASPs seek to exert influence on use of 
antimicrobials. One key mechanism, which has been used to great effect, is 
development of treatment guidelines. Generally created by consensus 
agreement on best practices for quality care delivery, adherence to treatment 
guidelines has previously been shown to be effective in reducing unnecessary 
antibiotic use101.  
     While misuse of antibiotics is well characterized, less is known about drivers 
of these events. Recent studies have demonstrated variation in adherence to 
treatment guidelines among care providers 53,54. Still the exact cause of these 
behaviors is not well understood. Recently it has also been shown that broad-






of broad-spectrum agent selection are even less understood at this point. 
However, both guideline appropriate and narrow-spectrum selection preference 
are seen as important mechanisms to help stem inappropriate antibiotic 
selection.  
     In addition to overall appropriateness of antibiotic prescribing, the type of 
agent prescribed is also of critical import. As a result, prescribing practices can 
be further evaluated according to guideline adherent prescribing and the 
prescribed antibiotic’s spectrum of activity.  Following our preliminary analyses, 
we hypothesized there would be increased non-guideline concordant and broad-
spectrum antibiotic prescribing observed in fall months. Thus, the goal of our 
study was to evaluate effects of season of clinical encounter on key quality 
metrics regarding antibiotic utilization in outpatient care settings for treatment of 









Study Design and Data Source 
     The current study involves a retrospective analysis of data derived from the 
National Ambulatory Medical Care Survey (NAMCS) from 2012 to 2015. 
Collected each year by the Centers for Disease Control and Prevention’s (CDC) 
National Center for Health Statistics (NCHS), NAMCS is a population-based, 
cross-sectional survey of patient visits to office-based physician practices in the 
United States (National Center for Health Statistics, 2013, Hyattsville, MD) and is 
useful to describe overall utilization of ambulatory care services in the US.  
     Eligibility for inclusion into the NAMCS survey is based on a multi-stage 
probability sample design where eligible patient visits are sampled among 
identified outpatient practices in the US. Each recorded visit is given a survey 
weight equal to the inverse of its selection probability at each given stage. As a 
result, these weights can be used to extrapolate survey results to nationally 
representative estimates of annual outpatient health services utilization in the 
US. NAMCS data are fully de-identified and made publicly available. As a result, 
the Institutional Review Board at the Boston University Medical Campus deemed 
the study exempt from formal human subjects protection review.   
     Over the study period, a total of 9,877 physicians were recruited, and annual 
response rates range from approximately 29% to 41%. Physicians were asked to 






2013 this form allotted space for up to three diagnoses codes and eight 
medication codes to be recorded. In subsequent years, fields were expanded to 
accommodate up to five diagnosis codes and 30 medication fields. NAMCS study 
personnel converted data from each visit into International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, and 
prescription drug data into Cerner Multum Lexicon codes. Multum Lexicon is a 
proprietary data system, containing therapeutic class information for all 
prescription medications available in the US67.  
 
 Study Sample and Definitions 
     Our study sample was initially drawn from 2,625 eligible outpatient office visits 
during which a diagnosis of pharyngitis was recorded. The study sample 
consisted of outpatient office visits attended by adults 18 years or older, which 
were associated with a primary, secondary, or tertiary diagnosis of acute 
pharyngitis. Cases of acute pharyngitis were identified by ICD-9 code 462. Visits 
in which multiple ARI diagnoses were noted were removed from our analyses. 
These rule-out ARI diagnoses included streptococcal sore throat (034), 
suppurative and non-suppurative otitis media (381, 382), acute nasopharyngitis 
(460), acute sinusitis (461), tonsillitis (463), non-specific ARI (465), bronchitis & 
bronchiolitis (466, 490), and bacterial pneumonias (481–486). Additionally, we 






use of antibiotics, since NAMCS data do not allow for linkage of recorded 
prescriptions to specific diagnoses. These non-ARI rule-out diagnoses (ICD-9-
CM) included non-specific cystitis (595), sexually transmitted infections (90–99, 
647), soft tissue infections (680–682), and urinary tract infections (599). 
     Antibiotics were defined as anti-infective agents according to their Multum 
Lexicon Plus Drug Database code assignment. The Multum database contains 
information regarding generic components and therapeutic class for all 
prescription medications available in the US. Antibiotic classes considered 
included cephalosporins, lincomycin derivatives, macrolides, penicillins, 
quinolones, tetracyclines, and miscellaneous agents. 
     Pharyngitis is considered an infection of the airway that may indicate 
prescription of antibiotics following clinical evaluation. We therefore considered 
an antibiotic prescription appropriate only if the prescribed medication met 2012 
IDSA guidelines regarding guideline concordant antibiotic therapy for acute 
pharyngitis in adults. According to these guidelines, concordant therapy involves 
either no antibiotic prescription, or in the case were an antibiotic is prescribed, 
either amoxicillin or amoxicillin / clavulanate are considered as first-line 
therapies. In the case of a known allergy to penicillin or other contraindication, 
cephalexin and cefadroxil were noted as suitable second-line alternatives. 
(Rahman et al, 2019.) An antibiotic prescription including one of these drugs was 






inappropriate. Patients prescribed multiple antibiotics were removed from 
analyses of appropriateness. 
     As a secondary measure of quality of observed antibiotic prescribing, we also 
evaluated likelihood of prescription of broad-spectrum antibiotics at each visit. 
Though broad-spectrum prescribing and its associated impacts has long been 
recognized as an issue in medical care69 less is known of any seasonal effects 
on this behavior. For the purpose of this analysis, broad-spectrum antibiotics 
were defined as broad-spectrum penicillins (e.g. amoxicillin & 
amoxicillin/Clavulanate), macrolides, second-, third-, fourth-, and fifth-generation 
cephalosporins, quinolones, and lincomycin derivatives. Narrow-spectrum 
antibiotics included narrow-spectrum penicillins, first-generation cephalosporins, 
sulfonamides, and tetracyclines100. This additional analysis allows us to redefine 
appropriateness of prescription in terms of spectrum of activity of the selected 
agent. We considered prescription of narrow-spectrum antibiotics to be 
appropriate, irrespective of treatment guidelines within this context.  
     We examined effects of relevant clinical and demographic variables of interest 
on likelihood of appropriate, and broad-spectrum antibiotic prescribing as distinct, 
binary outcomes. Data on patient age, sex, race & ethnicity (Non-Hispanic Black, 
Non-Hispanic White, Non-Hispanic Other, Hispanic), and insurance status 
(private, Medicaid, Medicare, self-pay, other, unknown), were included. Attending 






other), provider type (physician, physician assistant [PA], nurse practitioner 
[NP]/nurse-midwife [NMW], registered nurse [RN] / licensed practical nurse 
[LPN], other), region (Midwest, Northeast, South, West), and Metropolitan 
Statistical Area (MSA, non-MSA) were included as covariates of interest. Finally, 
in order to evaluate effects of season of clinical encounter on our dependent 
variables, we include season as a multi-level categorical variable in our analyses. 
Seasons were defined as winter (December, January, February), spring (March, 
April, May), summer (June, July, August), and fall (September, October, 
November).  
 
Statistical Analyses  
     We utilized available clustering, stratification and sampling weight variables to 
calculate nationally representative estimates, and relevant descriptive statistics 
for our study sample. All available years of data were combined in order to allow 
for increased power in our estimates.   
     Following adjustment for sampling design, we conducted bivariate analyses to 
evaluate significant associations between our two outcomes of interest: 1) 
likelihood of appropriateness of prescription as evidenced by guideline adherent 
therapy selection; and 2) likelihood of broad-spectrum antibiotic selection. 
Categorical variables were assessed via chi-squared tests and t tests were 






     We next fit a series of multivariate logistic regression models to evaluate 
effects of study variables on our dichotomous prescribing outcomes. In each 
model, we first evaluated main effects of covariates and following, looked for 
significant interactions between each model covariate with season. Covariates 
with an observed p-value < 0.2 in bivariate analyses were included in each 
multivariate model. We fit a series of models, removing the least significant 
covariate at each round. We repeated this process until all remaining variables in 
our models were significant. All analyses were conducted using SAS version 9.4 








     From 2012–2015, there were a total of 2,037 eligible visits in the NAMCS 
database that included a diagnosis of acute pharyngitis, or a weighted frequency 
of approximately 40 million visits recorded. To restrict our study population to 
adults, we excluded 1222 records, as the patient was younger than 18 years of 
age at the time of the clinical encounter. Another 25 visits were excluded due to 
concomitant, non-ARI conditions that could potentially warrant an antibiotic. 
Following application of study exclusion criteria, our analysis sample consisted of 
790 (17.5 M) unique, pharyngitis diagnosed outpatient visits. 
     Among the 790 visits that remained, mean patient age (SD) was 43 (18) 
years, and our study population was comprised largely of females (63%), and 
non-Hispanic whites (67%). Sixty-five percent of visits were associated with 
private source of payment, and a physician attended to 44% of recorded visits. 
Nearly 40% of visits occurred in the south, and pharyngitis office visits were 
recorded approximately equally during winter (25%) and spring months (24%). 
(Table 11) 
     Among recorded visits, roughly one-half (49%) resulted in an antibiotic 
prescription. Insurance status (p<0.0001) was strongly correlated with 
prescribing. While the bulk of prescriptions were written for privately insured 
patients (33%) to 85% (29/34) of self-pay visits resulted in antibiotic prescription. 






associated with antibiotic prescription events. Three quarters of all visits involving 
non-Hispanic/Other patients (34/53) resulted in a prescription. An attending 
physician wrote 21% of all prescriptions. Finally, season was identified as a 
significant predictor of prescribing (p=0.03); with the bulk of prescriptions written 
during spring months (n=113)/. (Table 11) 
     Among prescriptions written during recorded visits, the most commonly 
prescribed antibiotics were macrolides (40%), followed by penicillins (29%) and 
cephalosporins (12%). Together, these antibiotic classes accounted for more 
than 80% of all prescriptions recorded. (Figure 4A) There were approximately an 
even proportion of prescriptions written for penicillins during winter compared to 
macrolides (9.0% vs. 8.0%). Macrolides represented approximately 19% of all 
prescriptions written during fall, which was by far the greatest single season 
proportion of all antibiotics included in our analyses. Utilization of penicillins 
remained static over the study period, ranging from 5% of total use in summer to 
nearly 10% in fall. Utilization of cephalosporins peaked during summer season at 
roughly 4% of all antibiotics prescribed (p=0.004). (Figure 4B) 
 
Observed Broad-Spectrum Prescribing  
     Broad-spectrum antibiotics represented 40% of all antibiotics prescribed. Both 
race (0.009) and insurance status (<0.0001) were highly correlated with 






percent of all broad-spectrum, and 41% of all narrow-spectrum prescriptions 
were given to non-Hispanic white patients. Hispanic / Other were the only group 
observed with a greater proportion of broad-spectrum antibiotics prescribed 
compared to narrow-spectrum alternatives (9.0% vs. 3.0%). Regarding insurance 
status, broad-spectrum antibiotics were prescribed overwhelmingly at privately 
insured patient visits (26%). However, self-pay patient visits were the only 
payment type associated with greater total proportion of broad-spectrum agents 
prescribed, relative to narrow-spectrum (6.0% vs. 1.0%). (Table 12) 
     The greatest proportion of broad-spectrum agents was prescribed in fall 
(16%). Fall also represented the only season during which broad-spectrum 
agents were prescribed in greater proportion than narrow-spectrum agents. 
Prescription of narrow-spectrum antibiotics remained relatively stable, ranging 
from 13% to 15% each season (p=0.09). (Figure 5) 
 
Observed Guideline Appropriate Prescribing  
     We further classified antibiotic prescribing as appropriate or inappropriate 
based on guideline concordant antibiotic selection. As a result, we identified that 
roughly 70% of all visits for pharyngitis cases resulted in selection of a guideline 
appropriate first-line agent and were therefore considered appropriate. Race was 
strongly associated with appropriateness of prescribing, with nearly 51% of all 






Approximately 47% of all prescriptions written for privately insured patients were 
appropriate (p<0.0001). Non-Hispanic / Other race visits were the only category 
noted with greater proportion of inappropriate, relative to appropriate prescription 
events.  (Table 13) 
     Our bivariate analyses demonstrated season of clinical encounter was 
marginally associated with guideline appropriate antibiotic selection (p =0.06). 
We observed the greatest proportion of appropriate prescriptions during winter 
season (20%), while the greatest proportion of inappropriate prescriptions 
occurred during summer months (13%). (Figure 5) 
 
Multivariate Predictors of Broad-Spectrum Prescribing  
    Our data suggest insurance status is significantly predictive of broad-spectrum 
prescribing likelihood (p=0.03). We noted seasonal interactions between main 
effects of race (p<0.0001) and insurance type (p<0.0001). As such, we present 
main effects along with interaction terms in the final table. In the case of 
insurance type, self-pay patients had 0.17 times [OR (96%CI)] [0.18(0.053, 0.59)] 
likelihood of broad-spectrum antibiotic receipt compared to private pay source 
visits in fall season, and this estimate increased to nearly 18-fold during spring 
(p<0.0001). Although only marginally significant, non-Hispanic blacks were 
almost 3 times less likely to receive broad spectrum antibiotics than non-Hispanic 






Multivariate Predictors of Guideline Appropriate Prescribing  
     Our multivariable model showed significant interactions between insurance 
status and season on likelihood of guideline appropriate antibiotic selection. Age 
was negatively correlated with appropriate antibiotic selection, with each yearly 
increase in age leading to a 5 percent decrease in estimated probability of 
appropriate antibiotic selection. In the case of patient race & ethnicity, this overall 
effect was highly significant (p=<0.0001). Our data suggest Hispanics were less 
likely to receive guideline concordant therapy than non-Hispanic whites, even 
after controlling for season of encounter [OR (96%CI)] [0.0.12 (0.05, 0.27)]. 
Insurance status was also significantly associated with likelihood of appropriate 
prescribing (p<0.0001). Overall, self-pay patients were 11 times more likely, and 
Medicaid patients 13 times more likely to receive a guideline concordant 
antibiotic, when compared to visits involving private source of payment 
(p<0.0001). In the case of both payment types, the magnitude of this effect was 








     Our work has several main findings. Firstly, race and insurance status are 
each significant predictors of likelihood of guideline appropriate antibiotic 
prescribing for acute pharyngitis in outpatient settings. Our data suggest 
Hispanics were less likely to receive guideline appropriate therapy than non-
Hispanic whites during recorded visits. Interactions between race and season 
were not found to be significant. Self-pay and Medicaid patients were also more 
likely than privately insured patients to receive guideline appropriate therapy at 
study visits. Previously, minority children have been shown to be less likely to 
receive broad-spectrum antibiotics during clinic visits for OM and other diseases 
of the airway than are their white counterparts58,102. Our data suggest a similar 
pattern. Of course, the unintended consequence of this inequity is that less 
broad-spectrum antibiotic prescribing can actually be seen as beneficial, 
especially in young children. Still it is important to characterize drivers of these 
discrepancies.  
     Our focus on broad-spectrum prescribing is timely. In a promising trend, 
overall inappropriate utilization of antibiotics for viral ARIs has been on the 
decline over the last decade. Of concern is that use of broad-spectrum antibiotics 
was shown to increase by a factor of 4 over a similar period of time72. Use of 
broad-spectrum antimicrobials is associated with resistance and reduction of 






evidence that important drivers of observed variation in prescribing may lead to 
differential seasonal effects. Better grasp of specific drivers of broad-spectrum 
antibiotic prescribing could lend important insights into ASP activities and 
therapeutic guideline composition when considering timing of the prescribing 
event into consideration.  
     Also, of note is the observed prevalence of macrolide utilization. Here, we 
present data which demonstrate a high overall proportion of macrolide 
prescription (40%). Interestingly, macrolide utilization peaks during fall season 
(18%), which is more than twice as much as the next most prevalent period of 
use of this class of antibiotics. Overuse of macrolides has previously been shown 
to correlate with rates of multi-drug resistance patterns among pneumococci94. 
Our data provide some compelling evidence that in the case of pharyngitis 
treatment, misuse of antibiotics, including macrolides remains a significant public 
health concern. Further, data suggest temporal trends in their utilization that 
could be used to design novel ASP guidelines or educational programs.     
      Our findings offer several clinically relevant findings. Firstly, clinicians should 
be aware of inherent bias in care delivery to vulnerable patients. Our data 
highlight potential racial disparities in care delivery that may cause unintended, 
yet real harm in a small number of cases.  Secondly, our data provide useful 
targets for interventional strategies. We present findings showing a large amount 






narrow-spectrum antibiotics via formularies or seasonal restriction policies could 
be useful. Finally, physicians tended to prescribe narrow-spectrum antibiotics 
more frequently than other care providers. Physician knowledge, beliefs, or 
attitudes regarding appropriate antibiotic selection could be used to inform other 
health care providers via formal or informal training opportunities. There is also 
the issue of cost. Although, antibiotics are relatively inexpensive to purchase, 
collectively antibiotic prescriptions led to $11 billion in direct costs in a 2009 
study. The authors estimated that approximately 65% of this total cost ($6.5 
billion) occurred in outpatient settings. Further characterization of drivers of 
misuse in the ambulatory care setting is vital to development of stewardship 
activities designed to promote judicious use of antibiotic agents and could lead to 
significant cost savings in healthcare. 
     We recognize limitations of our research. One such limitation is lack of more 
granular clinical data. Centor criteria are critical in assessing quality of 
prescribing for diagnoses such as pharyngitis, OM, or sinusitis, which usually do 
not, but may necessitate antibiotic prescription in a small number of cases. 
Large, primary data sets such as NAMCS lack the level of clinical detail 
necessary to evaluate these quality of care details. For instance, practice 
guidelines are specific about the appropriate dose and duration of each antibiotic 
therapy prescribed. Given limitations of data contained in the NAMCS data set, 






antibiotic is selected and administered at an incorrect dose, this event would still 
represent inappropriate use and we are unable to track that.  
     Future studies should look further into the issue of race & ethnicity and 
differential temporal predictors of prescribing. The differential effects of study 
variables across seasons were modest, but apparent. In the fall, children are 
heading back to school and day care services. It is not uncommon for children to 
require an antibiotic prescription to attend day care facilities in cases of 
suspected illness. Perhaps, the observed increase in inappropriate prescriptions 
we see during this time period is due to persistence among parents during this 
season. Rooshenas and colleagues demonstrated in their 2014 mixed-
methodology study, that parents’ perceptions regarding day care facility antibiotic 
treatment requirements, had a direct impact on their antibiotic seeking 
behaviors103. A similar factor may be driving seasonal antibiotic seeking. Equally, 
providers could be dealing with heightened levels of diagnostic uncertainty, a key 
driver of antibiotic misuse 35 during fall seasons and provide an antibiotic in an 
attempt to remain conservative in their approach. More research, including mixed 
methodology and secondary data analyses will need to be completed in order to 
begin to explicate interactional effects with season of clinical encounter.  
     In summary, we provide novel evidence that race and insurance status are 
significant predictors of both guideline appropriate, and broad-spectrum antibiotic 






around which to design stewardship activities. Moving the needle with regards to 
total antibiotic prescribing may be helped along by understanding misuse of 
particular classes of antibiotics individually. Increases in proportion of guideline 
appropriate therapy, alongside decreases in broad-spectrum antibiotic selection 
could serve as useful targets and / or benchmarks for care providers in the 








Tables & Figures 
Table 11. Characteristics Associated With Adult Outpatient Pharyngitis 





Continuous Vars mean (std dev)
Age, years 0.26
Number of Chronic Conditions 0.51




     Female 0.32
Race 
     Hispanic
     Non-Hispanic Black
     Non-Hispanic Other
     Non-Hispanic White
Insurance
     Private
     Medicare
     Medicaid
     Self-Pay
     Other/Unknown
Provider
     Physician
     Physician Asst
     NP/NMW
     RN/LPN
     Other
Specialty
     General/Family Med
     Internal Med
     Pediatrics
     Other
Region
     Midwest
     Northeast
     South
     West 
Season
     Winter                                                           
     Spring
     Summer
     Fall 
Total n (%) Prescribed n (%) Not Prescribed n(%) 
19.5 (14.8) 19.9 (18.7) 19.1 (9.5)
0.45 (1.8) 0.41 (1.9) 0.50 (1.7)
42.5 (18.3) 41.8 (17.8) 43.3 (18.9)
488 (63.1) 241 (62) 247 (61)
682 (91.8) 362 (90)320 (82)
81 (14.5) 39 (10) 42 (10)
46 (6.7) 20 (5) 26 (7)
509 (65.0) 252 (65) 257 (64)
53 (11.8) 34 (9) 19 (5)
610 (67.1) 296 (76) 314 (78)
34 (7.9) 29 (7) 5 (1)
82 (7.9) 35 (9) 47 (12)
104 (11.1) 43 (11) 61 (15)
61 (8.0) 30 (8) 31 (8)
386 (44.3) 172 (44) 214 (53)
30 (4.8) 14 (4) 16 (4)
160 (30.9) 87 (22) 73 (18)
18 (2.14) 10 (3) 8 (2)
196 (17.9) 106 27) 90 (22)
159 (25.7) 83 (21) 76 (19)
50 (5.3) 21 (5) 29 (7)
352 (43.4) 191 (49) 161 (40)
202( 18.4) 99 (25) 103 (26)
229 (23.6) 94 (24) 135 (34)
112 (28)
122 (19.1) 60 (15) 62 (16)
288 (39.7) 155 (40) 133 (33)
0.03






183 (21.7) 86 (22) 97 (24)
162 (28.9) 81 (20) 81 (20)
220 (25) 109 (28) 111 (28)











Continuous Vars mean (std dev)
Age, years 0.007
Number of Chronic Conditions 0.57




     Female 0.68
Race 
     Hispanic
     Non-Hispanic Black
     Non-Hispanic Other
     Non-Hispanic White
Insurance
     Private
     Medicare
     Medicaid
     Self-Pay
     Other/Unknown
Provider
     Physician
     Physician Asst
     NP/NMW
     RN/LPN
     Other
Specialty
     General/Family Med
     Internal Med
     Pediatrics
     Other
Region
     Midwest
     Northeast
     South
     West 
Season
     Winter                                                           
     Spring
     Summer
     Fall 
Total n(%) 
N=755




0.44 (1.8) 0.40 (1.8) 0.48 (1.8)
19.5 (14.6) 18.9 (9.3)20.3 (19.9)
42.6 (18.3) 40.5 (17.4) 44.1 (18.9)
463 (62.3) 182 (60) 281 (63)
654 (92.6) 253 (83) 401 (89)
79 (14.9) 33 (11) 46 (10)
46 (7.0) 19 (6) 27 (3.9)
489 (65.7) 202 (66) 287 (64)
48 (12.1) 26 (8) 22 (2.9)
582 (66.0) 228 (75) 354 (40.7)
32 (7.6) 25 (8) 7 (2)
77 (7.6) 26 (9) 51 (11)
101 (11.2) 32 (10) 69 (15)
56 (7.9) 21 (7) 35 (8)
376 (44.6) 139 (45) 237 (53)
26 (4.9) 8 (3) 18 (4)
148  (30.2) 65 (21) 83 (19)
17 (2.2) 7 (2) 10 (2)
188 (18.0) 87 (28) 101 (22)
152 (25.1) 67 (22) 85 (19)
48 (5.0) 17 (6) 31 (7)
338 (45.8) 154 (50) 184 (41)
0.97
195 (8.2) 81 (26) 114 (26)
217 (24.1) 68 (22) 149 (33)
118 (19.2) 49 (16) 69 (15)
272 (38.5) 122 (40) 150 (33)
170 (23.4) 54 (18) 116 (26)
155 (28.3) 64 (21) 91 (24)
208 (25.5)  84 (27) 124 (28)

















Continuous Vars mean (std dev)
Age, years 0.04
Number of Chronic Conditions 0.71




     Female 0.81
Race 
     Hispanic
     Non-Hispanic Black
     Non-Hispanic Other
     Non-Hispanic White
Insurance
     Private
     Medicare
     Medicaid
     Self-Pay
     Other/Unknown
Provider
     Physician
     Physician Asst
     NP/NMW
     RN/LPN
     Other
Specialty
     General/Family Med
     Internal Med
     Pediatrics
     Other
Region
     Midwest
     Northeast
     South
     West 
Season
     Winter                                                           
     Spring
     Summer
     Fall 
Total n (%) 
N=719




0.46 (1.8) 0.43 (1.8) 0.48 (1.9)
19.5 (14.8) 19.2 (10.3) 20.7 (24.3)
42.5 (18.3) 41.9 (18.6) 45.2 (17.8)
437 (61.6)) 341 (62) 96 (57)
625 (93.1) 481 (87) 144 (86)
79 (15.6) 61 (11) 18 (11)
44 (7.1) 34 (6) 10 (6)
462 (64.9) 350 (64) 112 (67)
45 (12.4) 27 (5) 18 (11)
551 (64.9) 429 (78) 122 (76)
31 (7.8) 16 (3) 15 (9)
72 (7.5) 64 (12) 8 (5)
99 (11.5) 74 (13) 25 (15)
55 (8.2) 47 (8) 8 (5)
363 (45.3) 282 (50) 81 (48)
23 (4.4) 18 (4) 5 (3)
143 (31.1) 108 (19) 35 (21)
16 (2.1) 14 (2) 2 (1)
174 (17.1) 129 (24) 45 (27)
146 (24.3) 106 (19) 40 (24)
46 (5.1) 40 (7) 6 (4)
321 (45.9) 235 (43) 86 (51)
183 (18.0) 142 (26) 41 (24)
206 (24.5) 170 (31) 36 (21)
48 (29)
206 (23.4) 146 (27) 60 (36)
116 (19.8) 87 (15) 29 (17)
258 (36.5) 192 (35) 66 (39)







164 (21.6) 133 (24) 31 (18)
151 (29.1) 122 (22) 29 (17)






Figure 4. (4A) Distribution of Antibiotics Prescribed During Acute 
Pharyngitis Visits, 2012–2015. (4B) Distribution of Antibiotics Prescribed, 














































































































































Figure 5. Distribution of Broad- and Narrow-Spectrum Antibiotics 



































Figure 6. Distribution of Guideline Appropriate Prescribing, by Season of 















































F Vaulue p F Vaulue p
Season 3.1 0.03 4.2 0.006
Age -0.02 <0.0001 24.7 <0.0001
Insurance 0.14 0.14 0.03 0.85
Insurance*season 0.51 0.68 3 0.03












F Vaulue p F Vaulue p
Season 0.25 0.86 1.49 0.22
Age 0.02 <0.0001 0.55 0.65
insurance 0.08 0.41 4.74 0.03
Provider -0.13 0.03 0.05 0.82
Insurance*season 0.18 0.914 4.04 <0.0001
Provider*season 2.44 0.06 0.26 0.008








          In summary, there is a clear and worrying level of antibiotic misuse, and 
current evidence suggests season is an important driver of observed variation in 
utilization of this resource. Still, seasonal effects have only begun to be 
characterized. Thus, we set out to further disentangle relative effects of critical 
patient, provider, and clinical factors, previously identified as important drivers of 
antibiotic prescribing practices, within the context of seasonality. In pursuit of this 
goal, we deconstructed our main research question into three specific aims, each 
forming the basis of a separate study, presented below.  
 
Study 1: Seasonal Trends in Antibiotic Prescribing  
     As a first step, we set out to characterize the overall impact of seasonality as 
a driver of observed variation in antibiotic prescribing for acute respiratory 
infections, among adults in outpatient clinical settings. We focused on ARIs 
which predominate in ambulatory settings (e.g. sinusitis, pharyngitis, and otitis 
media, among others) as these infections are the main reason for ambulatory 
care visits among adults, as well as the main cause of antibiotic prescription in 
the United States72.   
     Our initial hypotheses were that we would be able to appropriately identify 
seasonal variation as measured by overall proportion of appropriate prescriptions 






interest. Secondly, we hypothesized bivariate analyses would uncover significant 
correlates of prescribing practices. Our main findings were that nearly one-half 
(48%) off all outpatient antibiotic prescribing for ARI remains inappropriate. 
Importantly, season was significantly associated with likelihood of appropriate 
prescribing for adult pharyngitis and suppurative and non-suppurative OM visits. 
We found marginal association between season and influenza and strep throat 
Overall, the most common antibiotics administered were Macrolides and 
Penicillins, accounting for nearly 60% of all prescriptions. However, we did not 
find evidence in support for our hypothesis regarding a seasonal association 
underlying antibiotic class selection. 
 
Study 2: Drivers Of Observed Seasonal Variation 
     Our next set of analyses was designed to characterize specific drivers of 
observed seasonal variation among those ARIs we identified as demonstrating a 
significant seasonal component. As such, we subset our original data set to only 
those visits with a diagnosis of pharyngitis or OM. We found that antibiotics were 
again prescribed in 46% of all pharyngitis or OM visits during the study period. 
Macrolides (35%) and penicillins (34%) accounted for the bulk of all prescriptions 
written. One-half (49%) of prescribing for pharyngitis was inappropriate. We 
observed slightly less (30%) inappropriate prescribing among visits for OM. 






predictors of prescribing appropriateness during OM visits. We also identified a 
significant interaction between season of encounter and insurance status during 
OM visits. Finally, multivariate analyses identified insurance status and provider 
type as having a significant interaction with season during pharyngitis visits. 
 
Study 3: Implications For Care & Quality     
     Recent studies have demonstrated variation in not only the overall prevalence 
of prescribing 12 but also in adherence to prescribing guidelines and, variation in 
selection of narrow- vs. broad-spectrum antibiotic agent. Guideline appropriate 
therapy, and narrow-spectrum preference are seen as important ways to promote 
judicious use of antibiotics. Less is known of seasonal effects on these additional 
aspects of antibiotic prescribing. As a final set of analyses, we set out to describe 
seasonal influence on guideline adherence and likelihood of broad-spectrum 
antibiotic selection among adult pharyngitis visits to outpatient clinics. Antibiotics 
were prescribed in 49% of pharyngitis visits and season was found to 
significantly correlate which appropriate prescribing. Macrolides, penicillins, and 
cephalosporins accounted for ~80% of all noted prescriptions. Broad-spectrum 
antibiotics represented approximately 40% of all prescriptions, and were more 
likely to be written to Hispanics, privately insured patients, and during fall. 







     In line with previous research, the most common ARI diagnoses observed 
were common cold, sinusitis, and acute bronchitis. Previously, these ARIs have 
accounted for 70% of outpatient visits 69 , while here we observed roughly 60% of 
these diagnoses among all visits. Previously, studies have reported as much as 
50% of all outpatient prescribing is inappropriate 87. We have identified a similar 
proportion (48%), and thus are confident in our approach to case identification. 
Previous work on seasonal variation in antibiotic prescribing suggests the 
majority of prescribing occurs in winter12, and our data provide evidence to 
support these findings. We also note the greatest proportion of inappropriate 
prescribing during winter seasons. Macrolides represented the most common 
class of antibiotic observed in our data set. Recent studies have also identified 
relatively elevated levels of macrolide prescribing, as well as potentially 
associated patient harms.  
     To the best of our knowledge, this work represents a novel use of nationally 
representative data to describe observed seasonal variation in use of antibiotics 
for treatment of ARI in adults. Much previous research on seasonal effects on 
antibiotic prescribing looked at all-cause prescribing lacked large, nationally 
representative data sets for analyses104, or were not US based Thus, a relative 
strength of our analyses is the ability to extrapolate to adult, ARI related 
outpatient visits in the United States with a degree of confidence in findings. 






between prescribing factors and season of clinical encounter. These predictors 
offer unique information when combined with secondary date that can support a 
reasonable underlying theory on mechanism. Seasonal fluctuation in 
determinants of ARI, and care seeking is likely at play here. Our work offers a 
first glimpse at how seasonality may affect outpatient antibiotic prescribing 
specifically for sore throat and OM, two ARI diagnoses with a relatively elevated 
level of associated inappropriate antibiotic utilization.  
     Our findings suggest some key insights. Firstly, we found race to be a 
significant predictor antibiotic prescribing. Previous research has shown that 
black children were less likely to receive inappropriate treatment for OM58,102 
compared to white children, while we provide evidence for greater proportion of 
inappropriate prescribing among Hispanics.  While not statistically significant, we 
did find evidence that visits with non-Hispanic African American adults were also 
less likely to result in an inappropriate prescription compared to visits with white 
patients. Future research should focus on racial disparities in order to identify 
interventional targets. We also found seasonal differences among insurance 
types at study visits for treatment of pharyngitis and OM. In general, privately 
insured patients were more likely to receive an inappropriate antibiotic and the 
magnitude of this effect was greatest in spring. Additional analyses will need to 
further investigate patient and provider perceptions and how these are altered 






     Lastly, we provide data that suggest time pressure may not be as predictive 
as assumed when additional factors, including season are controlled for in 
multivariate prediction models. Patient volume is seen as a proxy for time 
pressure, with increases in visit numbers leading to increased time pressure. 
Heightened time pressure is generally associated with increased likelihood of 
prescribing. Here, we provide evidence, that at least in the cases of some ARIs, 
seasons with the greatest numbers of visits are not associated with greatest 
proportion of antibiotic misuse. Future research will need to incorporate different 
elements of the clinic visit that may have an interactive effect, for example patient 
symptom presentation, or point of care testing availability, and how these interact 
to affect the prescribing event.  
     Overall, misuse of antibiotics remains a critical concern in healthcare. 
Development of new antibiotic agents has all but ceased, yet emergence of 
resistance among microorganisms continues at an alarming rate. These realities 
have caused the WHO organization to warn, that but for sweeping changes to 
prescribing practices, we are quickly returning to a pre-antibiotic era (WHO, 
2012). ACP guidelines suggest that in the case of acute bronchitis, prescribing 
rates should be 0%, yet we still observe rates >70% in the literature. Clearly 
more must be done to understand why this occurs, and how to address the issue.  
     In one attempt to promote rational use of antibiotics, the White House 






forth as a stated goal to realize a 50% reduction in inappropriate use of 
antibiotics at the national level. As we arrive at this milestone, there clearly 
remains much work to do on behalf of health care professional and researcher 
alike to reach this goal. In support of these efforts, we present data on the overall 
influence of season on antibiotic prescribing in an attempt to more fully inform 
development and dissemination of interventions designed to address this 
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